1 |
(-)-3-(4-aminophenyl)-2-methoxypropionic acid |
- |
- |
- |
- |
097 [1] 97 💬 |
2 |
(r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid |
Butyric Acid |
[1] D05866 D05866 💬 |
- |
- |
097 [1] 97 💬 |
3 |
(s)-(-)-3-(4-aminophenyl)-2-methoxypropionic acid |
- |
- |
- |
- |
097 [1] 97 💬 |
4 |
(s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben |
- |
- |
- |
- |
097 [1] 97 💬 |
5 |
(s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride |
- |
- |
- |
- |
097 [1] 97 💬 |
6 |
-aminosalicylic acid |
Aminosalicylic acid |
[1] D00162 D00162 💬 |
- |
- |
096 [2] 96, 97 💬 |
7 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
8 |
0.25mg rpc103 |
- |
- |
- |
- |
097 [1] 97 💬 |
9 |
0.25mg rpc1063 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
10 |
0.5 mg rpc1063 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
11 |
1 mg rpc1063 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
12 |
1.0 mg rpc103 |
- |
- |
- |
- |
097 [1] 97 💬 |
13 |
1.0 mg rpc1063 |
- |
- |
- |
- |
097 [1] 97 💬 |
14 |
1.remicade |
- |
- |
- |
- |
097 [1] 97 💬 |
15 |
10 mg natura-alpha capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
16 |
100 |
- |
- |
- |
- |
006 [2] 6 , 97 💬 |
17 |
100 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
18 |
150 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
19 |
1500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
20 |
15n2-tofacitinib |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
21 |
2 x 10 mg natura-alpha capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
22 |
2'-fucosyllactose |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
23 |
2-hydroxybenzoic acid |
Salicylic acid |
[1] D00097 D00097 💬 |
- |
- |
097 [1] 97 💬 |
24 |
20 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
25 |
225mg shp647 (pf-00547659) |
- |
- |
- |
- |
097 [1] 97 💬 |
26 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
27 |
25 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 [2] 96, 97 💬 |
28 |
250mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
29 |
2l polyethylene glycol/ascorbic acid |
Ascorbic acid |
[2] D00018 D00018, D03370 D03370 💬 |
- |
- |
097 [1] 97 💬 |
30 |
3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) |
Tromethamine |
[1] D00396 D00396 💬 |
- |
- |
096 [2] 96, 97 💬 |
31 |
331731-18-1 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
32 |
40 mg msb11022 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
33 |
42942019 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
34 |
450 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
35 |
5 asa, enemas, suppositories, corticosteroids |
- |
- |
- |
- |
097 [1] 97 💬 |
36 |
5-amino salicylic acid |
Salicylic acid |
[1] D00097 D00097 💬 |
- |
- |
097 [1] 97 💬 |
37 |
5-amino salicylic acid (5-asa) |
Mesalazine |
[2] D00097 D00097, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
38 |
5-amino-2-hydroxybenzoic acid |
Salicylic acid |
[1] D00097 D00097 💬 |
- |
- |
097 [1] 97 💬 |
39 |
5-aminosalicyclic acid |
- |
- |
- |
- |
097 [1] 97 💬 |
40 |
5-aminosalicylate (pentasa, ferring) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
41 |
5-aminosalicylic acid |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
096 [2] 96, 97 💬 |
42 |
5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
43 |
5-aminosalicylic acid(5-asa) and/or prednisone |
Aminosalicylic acid |
[3] D00162 D00162, D00377 D00377, D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
44 |
5-asa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [2] 96, 97 💬 |
45 |
5-asa (5-aminosalicylate) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
46 |
5-asa mmx |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
47 |
5-htp |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
48 |
50 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
49 |
500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
50 |
549-0261/f02-01 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
51 |
6 mercaptopurine |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
52 |
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid |
- |
- |
- |
- |
097 [1] 97 💬 |
53 |
6-mercaptopurine |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [3] 96, 97, 164 💬 |
54 |
6-mp |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
55 |
75 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 [2] 96, 97 💬 |
56 |
750mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
57 |
75mg shp647 (pf-00547659) |
- |
- |
- |
- |
097 [1] 97 💬 |
58 |
90 mg hydrocortisone acetate suppository with sephure suppository applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
59 |
[124i]ib pf 06687234 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
60 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
61 |
[18f]fspg |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
62 |
[bi 655130] |
- |
- |
- |
- |
097 [1] 97 💬 |
63 |
[cc-10004] |
- |
- |
- |
- |
097 [1] 97 💬 |
64 |
[n/a] |
- |
- |
- |
- |
097 [2] 97, 299 💬 |
65 |
A multistrain probiotic product (dsf) |
- |
- |
- |
- |
097 [1] 97 💬 |
66 |
A07da03 |
- |
- |
- |
- |
097 [1] 97 💬 |
67 |
A: 1 dosis |
- |
- |
- |
- |
097 [1] 97 💬 |
68 |
Ab (antibiotics) |
- |
- |
- |
- |
097 [1] 97 💬 |
69 |
Abalimumab |
- |
- |
- |
- |
097 [1] 97 💬 |
70 |
Abatacept |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
71 |
Abatacept (aba) |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
097 [1] 97 💬 |
72 |
Abbv-006 |
- |
- |
- |
- |
097 [1] 97 💬 |
73 |
Abbv-066 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
74 |
Abbv-323 |
- |
- |
- |
- |
053 [2] 53, 97 💬 |
75 |
Abbv-323 dose a |
- |
- |
- |
- |
097 [1] 97 💬 |
76 |
Abbv-323 dose b |
- |
- |
- |
- |
097 [1] 97 💬 |
77 |
Abgn-168h |
- |
- |
- |
- |
097 [1] 97 💬 |
78 |
Abi-m201 |
- |
- |
- |
- |
097 [1] 97 💬 |
79 |
Abrilumab |
Abrilumab |
[1] D10540 D10540 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
80 |
Abt-494 |
- |
- |
- |
- |
041 [6] 41, 46, 49, 96, 97, 271 💬 |
81 |
Abt-humira |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
82 |
Abx464 |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
83 |
Abx464 100mg |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
84 |
Abx464 25mg |
- |
- |
- |
- |
097 [1] 97 💬 |
85 |
Abx464 50mg |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
86 |
Accelerated 1 hour-infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
87 |
Accelerated 30 minutes-infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
88 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
89 |
Acetic acid |
Acetic acid |
[1] D00010 D00010 💬 |
- |
- |
097 [1] 97 💬 |
90 |
Acidophilus |
Lactobacillus acidophilus |
[1] D04349 D04349 💬 |
- |
- |
097 [1] 97 💬 |
91 |
Active group |
- |
- |
- |
- |
097 [1] 97 💬 |
92 |
Adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 [16] 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬 |
93 |
Adipate |
Iron (III) oxide adipate |
- |
- |
- |
097 [2] 97, 228 💬 |
94 |
Adipose derived, autologous mesenchymal stem cells |
- |
- |
- |
- |
097 [1] 97 💬 |
95 |
Adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 [1] 97 💬 |
96 |
Adipose-cord mesenchymal stromal cells (a-mscs) |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
097 [1] 97 💬 |
97 |
Aeb071 |
- |
- |
- |
- |
097 [1] 97 💬 |
98 |
Aeb071a |
- |
- |
- |
- |
097 [1] 97 💬 |
99 |
Ag011 |
- |
- |
- |
- |
097 [1] 97 💬 |
100 |
Ag011 - capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
101 |
Ag011 - enema |
- |
- |
- |
- |
097 [1] 97 💬 |
102 |
Air |
- |
- |
- |
- |
003 [7] 3 , 51, 58, 85, 97, 193, 299 💬 |
103 |
Ajg501 |
- |
- |
- |
- |
097 [1] 97 💬 |
104 |
Ajg511 |
- |
- |
- |
- |
097 [1] 97 💬 |
105 |
Ajm300 |
- |
- |
- |
- |
097 [1] 97 💬 |
106 |
Aldesleukin |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [4] 49, 65, 96, 97 💬 |
107 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 [2] 96, 97 💬 |
108 |
Alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 [4] 46, 93, 97, 172 💬 |
109 |
Allogeneic adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 [1] 97 💬 |
110 |
Allopurinol |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 [6] 6 , 46, 57, 66, 96, 97 💬 |
111 |
Aloasc |
- |
- |
- |
- |
097 [1] 97 💬 |
112 |
Aloe |
Aloe Vera Leaf |
- |
- |
- |
097 [1] 97 💬 |
113 |
Aloe barbadensis miller |
Aloe Vera Leaf |
- |
- |
- |
097 [1] 97 💬 |
114 |
Alth12-1:4 |
- |
- |
- |
- |
097 [1] 97 💬 |
115 |
Alth12-2:4 |
- |
- |
- |
- |
097 [1] 97 💬 |
116 |
Amg 181 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
117 |
Amg181 |
- |
- |
- |
- |
097 [1] 97 💬 |
118 |
Amgevita |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
119 |
Amgevita (adalimumab biosimilar ) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
120 |
Amgevita 40 mg injektionslösung im fertigpen |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
121 |
Amgevita 40 mg injektionslösung in einer fertigspritze |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
122 |
Amgevita 40mg solution for injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
123 |
Amgevita® |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
124 |
Aminosalicylic acid |
Aminosalicylic acid |
[1] D00162 D00162 💬 |
- |
- |
096 [2] 96, 97 💬 |
125 |
Amitriptyline |
Amitriptyline |
[2] D00809 D00809, D07448 D07448 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
078 [4] 78, 97, 226, 299 💬 |
126 |
Amitriptyline hydrochloride |
Amitriptyline |
[2] D00809 D00809, D07448 D07448 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
097 [1] 97 💬 |
127 |
Amoxicillin |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 [7] 6 , 46, 63, 96, 97, 222, 299 💬 |
128 |
Amoxicillin and tetracycline |
Amoxicillin |
[4] D00201 D00201, D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
097 [1] 97 💬 |
129 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
[7] D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
097 [1] 97 💬 |
130 |
Amt |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
131 |
Amt-101 |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
132 |
Amt-101 (oral) |
- |
- |
- |
- |
097 [1] 97 💬 |
133 |
Anakinra |
Anakinra |
[1] D02934 D02934 💬 |
IL1R1 [2] IL1R1, IL1R2 💬 |
Amoebiasis [15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 [17] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
134 |
And (andrographolide) |
Andrographolide |
- |
- |
- |
097 [1] 97 💬 |
135 |
Andecaliximab |
- |
- |
- |
- |
046 [4] 46, 96, 97, 299 💬 |
136 |
Andosan |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
137 |
Andrographis paniculata |
- |
- |
- |
- |
097 [1] 97 💬 |
138 |
Andrographis paniculata (ethanol extract) |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
097 [1] 97 💬 |
139 |
Andrographolide |
Andrographolide |
- |
- |
- |
097 [1] 97 💬 |
140 |
Anrukinzumab |
Anrukinzumab |
[1] D08857 D08857 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
097 [1] 97 💬 |
141 |
Anti beta7 |
- |
- |
- |
- |
097 [1] 97 💬 |
142 |
Anti cd3 monoclonal antibody |
- |
- |
- |
- |
097 [1] 97 💬 |
143 |
Anti tnf therapy including infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
144 |
Anti-cd3 |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
145 |
Anti-cd3 monoclonal antibody |
Muromonab |
[1] D05092 D05092 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
146 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
147 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
148 |
Anti-ip-10 antibody |
- |
- |
- |
- |
097 [1] 97 💬 |
149 |
Anti-madcam antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
150 |
Anti-tl1a |
- |
- |
- |
- |
097 [1] 97 💬 |
151 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
152 |
Anti-tnf drug |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
153 |
Anti-tnf therapy |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
154 |
Anti-tnf: infliximab (infusion) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
155 |
Anti-tnf:adalimumab (subcutaneus) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
156 |
Antibiotic cocktail |
- |
- |
- |
- |
097 [1] 97 💬 |
157 |
Aodg (apigenin-7-o-glucuronide) |
Apigenin |
- |
- |
- |
097 [1] 97 💬 |
158 |
Apd334 |
- |
- |
- |
- |
093 [4] 93, 96, 97, 269 💬 |
159 |
Apigenin |
Apigenin |
- |
- |
- |
097 [1] 97 💬 |
160 |
Apixaban |
Apixaban |
[1] D03213 D03213 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
096 [3] 96, 97, 222 💬 |
161 |
Apixaban 2.5 milligram |
Apixaban |
[1] D03213 D03213 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
096 [2] 96, 97 💬 |
162 |
Apremilast |
Apremilast |
[1] D08860 D08860 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 [6] 46, 50, 56, 97, 162, 271 💬 |
163 |
Apriso 0.375g er cap |
- |
- |
- |
- |
097 [1] 97 💬 |
164 |
Apriso 375 mg extended-release capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
165 |
Apvo210 |
- |
- |
- |
- |
097 [1] 97 💬 |
166 |
Aquamin® |
- |
- |
- |
- |
097 [1] 97 💬 |
167 |
Ar401959 l-arginine |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
096 [2] 96, 97 💬 |
168 |
Arginine |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
046 [9] 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
169 |
As |
- |
- |
- |
- |
046 [6] 46, 53, 96, 97, 215, 271 💬 |
170 |
As inn |
- |
- |
- |
- |
097 [1] 97 💬 |
171 |
Asa |
- |
- |
- |
- |
013 [4] 13, 96, 97, 251 💬 |
172 |
Asacol |
- |
- |
- |
- |
097 [1] 97 💬 |
173 |
Asacol (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
174 |
Asacol (mesalamine) delayed-release tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
175 |
Asacol 400 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
176 |
Asacol 400 mg (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
177 |
Asacol 400 mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
178 |
Asacol 400mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
179 |
Asacol 800 mg (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
180 |
Asacol 800 mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
181 |
Asacol 800mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
182 |
Asacol delayed release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
183 |
Asacol delayed-release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
184 |
Asacol tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
185 |
Asacol® |
- |
- |
- |
- |
097 [1] 97 💬 |
186 |
Asacol® 400 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
187 |
Asc |
- |
- |
- |
- |
036 [4] 36, 51, 96, 97 💬 |
188 |
Ascorbic acid |
Ascorbic acid |
[1] D00018 D00018 💬 |
- |
- |
010 [4] 10, 97, 206, 298 💬 |
189 |
Asp015k |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
190 |
Asp3291 |
- |
- |
- |
- |
097 [1] 97 💬 |
191 |
Aspergillus oryzae |
Aspergillus oryzae |
- |
- |
- |
097 [1] 97 💬 |
192 |
Ast-120 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
193 |
Atl-2502 |
ATL-2502 |
- |
- |
- |
097 [1] 97 💬 |
194 |
Avonex |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
195 |
Avx 470 |
- |
- |
- |
- |
097 [1] 97 💬 |
196 |
Aza |
- |
- |
- |
- |
011 [4] 11, 40, 96, 97 💬 |
197 |
Azafor 50mg |
- |
- |
- |
- |
097 [1] 97 💬 |
198 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
199 |
Azathioprine (aza) |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
013 [3] 13, 19, 97 💬 |
200 |
Azathioprine (aza) or 6-mercaptopurine (6-mp) |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
201 |
Azathioprine (imuran) 50 mg overencapsulated tablet |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
097 [1] 97 💬 |
202 |
Azathioprine and allopurinol |
Allopurinol |
[3] D00224 D00224, D00238 D00238, D03033 D03033 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
097 [1] 97 💬 |
203 |
Azathioprine or 6-mercaptopurine |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [2] 96, 97 💬 |
204 |
Azatioprina |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
013 [3] 13, 96, 97 💬 |
205 |
B2-asmedic |
- |
- |
- |
- |
097 [1] 97 💬 |
206 |
B: 2 dosis |
- |
- |
- |
- |
097 [1] 97 💬 |
207 |
Bacteriotherapy |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
208 |
Balsalazide |
Balsalazide |
[2] D02715 D02715, D07488 D07488 💬 |
- |
- |
097 [1] 97 💬 |
209 |
Balsalazide disodium |
Balsalazide |
[2] D02715 D02715, D07488 D07488 💬 |
- |
- |
097 [1] 97 💬 |
210 |
Baminercept |
Baminercept |
[1] D08866 D08866 💬 |
LTB [1] LTB 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [4] 13, 46, 53, 97 💬 |
211 |
Band |
- |
- |
- |
- |
006 [2] 6 , 97 💬 |
212 |
Bascial prescription plus or minus herbs depend on symptoms |
- |
- |
- |
- |
097 [1] 97 💬 |
213 |
Basiliximab |
Basiliximab |
[1] D03058 D03058 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [6] 2 , 50, 65, 97, 222, 228 💬 |
214 |
Bbt-401-1s |
- |
- |
- |
- |
097 [1] 97 💬 |
215 |
Bbt-401-1s, multiple doses |
- |
- |
- |
- |
097 [1] 97 💬 |
216 |
Bbt-401-1s, single dose |
- |
- |
- |
- |
097 [1] 97 💬 |
217 |
Beclometasone |
- |
- |
- |
- |
097 [1] 97 💬 |
218 |
Beclometasone dipropionate |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [2] 85, 97 💬 |
219 |
Beclomethasone dipropionate |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [2] 97, 98 💬 |
220 |
Beclomethasone diproprionate |
- |
- |
- |
- |
097 [1] 97 💬 |
221 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
222 |
Behavioral: administration of probiotic (l. rhamnosus and l. acidophilus) |
Lactobacillus acidophilus |
[1] D04349 D04349 💬 |
- |
- |
097 [1] 97 💬 |
223 |
Behavioral: increased dietary intake of salmon or cod |
Salmon, unspecified |
- |
- |
- |
097 [1] 97 💬 |
224 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
225 |
Berberine |
Berberine |
[1] D00092 D00092 💬 |
- |
- |
097 [1] 97 💬 |
226 |
Berberine chloride |
Berberine |
[1] D00092 D00092 💬 |
- |
- |
097 [1] 97 💬 |
227 |
Bertilimumab |
- |
- |
- |
- |
097 [2] 97, 162 💬 |
228 |
Beta-1,3/1,6-d-glucan |
- |
- |
- |
- |
097 [1] 97 💬 |
229 |
Bezlotoxumab |
Bezlotoxumab |
[1] D10453 D10453 💬 |
- |
- |
096 [2] 96, 97 💬 |
230 |
Bg9418 (interferon beta-1a) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [2] 13, 97 💬 |
231 |
Bg9924 |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
232 |
Bi 655130 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
233 |
Biap |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
234 |
Bifidobacterium breve |
MRx-4DP0004 |
- |
- |
- |
097 [1] 97 💬 |
235 |
Bifidobacterium infantis |
Bifidobacterium longum infantis |
- |
- |
- |
096 [2] 96, 97 💬 |
236 |
Bifidobacterium infantis 35624 |
Bifidobacterium longum infantis |
- |
- |
- |
096 [2] 96, 97 💬 |
237 |
Bimekizumab |
Bimekizumab |
[1] D11550 D11550 💬 |
IL17A [2] IL17A, IL17F 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
046 [3] 46, 97, 271 💬 |
238 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [1] 97 💬 |
239 |
Biologically active human fecal microbiota |
- |
- |
- |
- |
097 [1] 97 💬 |
240 |
Biopsies |
- |
- |
- |
- |
097 [1] 97 💬 |
241 |
Biosimilar |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
242 |
Biosimilar infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
243 |
Bitter candytuft fresh plant extract |
- |
- |
- |
- |
097 [1] 97 💬 |
244 |
Bitterschleifenblume-ganzpflanze 1,5ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
245 |
Bl-7040 |
- |
- |
- |
- |
097 [1] 97 💬 |
246 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
247 |
Blood samples |
- |
- |
- |
- |
013 [8] 13, 41, 46, 51, 61, 97, 227, 271 💬 |
248 |
Bms-188667 |
- |
- |
- |
- |
046 [8] 46, 49, 53, 65, 96, 97, 222, 271 💬 |
249 |
Bms-936557 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
250 |
Bms-986165 |
- |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
251 |
Bms-986165 dose 1 |
- |
- |
- |
- |
097 [1] 97 💬 |
252 |
Bms-986165 dose 2 |
- |
- |
- |
- |
097 [1] 97 💬 |
253 |
Bms-986166 |
- |
- |
- |
- |
097 [1] 97 💬 |
254 |
Bms-986184 |
- |
- |
- |
- |
097 [1] 97 💬 |
255 |
Bms986165 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
256 |
Boulardii |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
257 |
Bovine intestinal alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
258 |
Bovine-calf alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
259 |
Bovine-calf alkaline phosphatase biap |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
260 |
Brazikumab |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
261 |
Broccoli |
Broccoli |
- |
- |
- |
036 [3] 36, 97, 299 💬 |
262 |
Bt-11 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
263 |
Bt-11 (1000 mg) |
- |
- |
- |
- |
097 [1] 97 💬 |
264 |
Bt-11 (500 mg) |
- |
- |
- |
- |
097 [1] 97 💬 |
265 |
Bt-11 1000mg |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
266 |
Bt-11 500 mg |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
267 |
Bt-11 active |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
268 |
Budenofalk 2mg rectal foam |
- |
- |
- |
- |
097 [1] 97 💬 |
269 |
Budenofalk 3mg |
- |
- |
- |
- |
093 [2] 93, 97 💬 |
270 |
Budenofalk rectal foam |
- |
- |
- |
- |
097 [1] 97 💬 |
271 |
Budenofalk® suppositories |
- |
- |
- |
- |
097 [1] 97 💬 |
272 |
Budenofalk® suppositories (bus) |
- |
- |
- |
- |
097 [1] 97 💬 |
273 |
Budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
274 |
Budesonide (6 mg) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
275 |
Budesonide (9 mg) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
276 |
Budesonide 6 mg capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
277 |
Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
278 |
Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
279 |
Budesonide 9 mg capsules, hard (bux-pv) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
280 |
Budesonide 9 mg capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
281 |
Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
282 |
Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
283 |
Budesonide mmx |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
284 |
Budesonide mmx 6 mg tablet |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
285 |
Budesonide mmx® |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
286 |
Budesonide mmx® 6 mg |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
287 |
Budesonide mmx® 9 mg |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
288 |
Budesonide-mmx |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
289 |
Budesonide-mmx® |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
290 |
Budesonide-mmx® 6 mg |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
291 |
Budesonide-mmx® 9 mg |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
292 |
Budesonide-mmx™ |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
293 |
Butanoic acid |
Butyric Acid |
[1] D05866 D05866 💬 |
- |
- |
034 [3] 34, 51, 97 💬 |
294 |
Butyrate |
Butyric Acid |
[1] D05866 D05866 💬 |
- |
- |
097 [2] 97, 291 💬 |
295 |
By demand |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
296 |
Caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
297 |
Caffeine 100 mg |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [2] 96, 97 💬 |
298 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 [2] 96, 97 💬 |
299 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
300 |
Caltrate pill |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
301 |
Cannabidiol |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [17] 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
302 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 [8] 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
303 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 [5] 2 , 6 , 13, 96, 97 💬 |
304 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
305 |
Carbon dioxide |
Activated charcoal |
[2] D00004 D00004, D03251 D03251 💬 |
- |
- |
050 [3] 50, 51, 97 💬 |
306 |
Carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [8] 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
307 |
Carrageenan |
- |
- |
- |
- |
097 [1] 97 💬 |
308 |
Carvi extractum fluidum |
- |
- |
- |
- |
097 [1] 97 💬 |
309 |
Casein |
Casein |
- |
- |
- |
097 [1] 97 💬 |
310 |
Casein glycomacropeptide (cgmp) |
Casein |
- |
- |
- |
097 [1] 97 💬 |
311 |
Cat-354 |
- |
- |
- |
- |
097 [1] 97 💬 |
312 |
Catridecacog |
Catridecacog |
[1] D10532 D10532 💬 |
- |
- |
097 [2] 97, 288 💬 |
313 |
Cb-01-02 |
- |
- |
- |
- |
097 [1] 97 💬 |
314 |
Cb-01-05-mmx |
- |
- |
- |
- |
097 [1] 97 💬 |
315 |
Cc |
- |
- |
- |
- |
013 [13] 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
316 |
Cc-10004 |
- |
- |
- |
- |
046 [5] 46, 56, 97, 162, 271 💬 |
317 |
Cd |
- |
- |
- |
- |
006 [6] 6 , 46, 51, 96, 97, 265 💬 |
318 |
Ceftriaxone |
Ceftriaxone |
[2] D00924 D00924, D07659 D07659 💬 |
- |
- |
002 [3] 2 , 6 , 97 💬 |
319 |
Cefuroxime |
Cefuroxime |
[4] D00262 D00262, D00914 D00914, D00915 D00915, D03431 D03431 💬 |
- |
- |
097 [2] 97, 299 💬 |
320 |
Certolizumab pegol |
Certolizumab pegol |
[1] D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 [6] 37, 46, 96, 97, 226, 271 💬 |
321 |
Cgmp protein |
- |
- |
- |
- |
097 [1] 97 💬 |
322 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
323 |
Chlorogenic acid |
Chlorogenic Acid |
- |
- |
- |
097 [1] 97 💬 |
324 |
Cholecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [9] 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
325 |
Ciclosporin |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 [13] 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
326 |
Ciclosporina |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
049 [3] 49, 97, 228 💬 |
327 |
Cimzia |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
328 |
Ciprofloxacin |
Ciprofloxacin |
[2] D00186 D00186, D02216 D02216 💬 |
- |
- |
002 [5] 2 , 60, 96, 97, 299 💬 |
329 |
Cla |
- |
- |
- |
- |
097 [1] 97 💬 |
330 |
Cla (chlorogenic acid) |
Chlorogenic Acid |
- |
- |
- |
097 [1] 97 💬 |
331 |
Clarithromycin |
Clarithromycin |
[1] D00276 D00276 💬 |
- |
- |
006 [8] 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
332 |
Clipper |
- |
- |
- |
- |
097 [1] 97 💬 |
333 |
Clipper 30 cpr 5mg r.m. |
- |
- |
- |
- |
097 [1] 97 💬 |
334 |
Clipper*30cpr 5mg r.m. |
- |
- |
- |
- |
097 [1] 97 💬 |
335 |
Clotrimazole |
Clotrimazole |
[1] D00282 D00282 💬 |
- |
- |
097 [1] 97 💬 |
336 |
Cnto 148 |
- |
- |
- |
- |
046 [4] 46, 84, 97, 271 💬 |
337 |
Cnto-148 |
- |
- |
- |
- |
097 [1] 97 💬 |
338 |
Cnto1275 |
- |
- |
- |
- |
046 [6] 46, 49, 84, 93, 96, 97 💬 |
339 |
Cnto148 |
- |
- |
- |
- |
046 [3] 46, 84, 97 💬 |
340 |
Cnto1959 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
341 |
Cnto312 |
- |
- |
- |
- |
097 [1] 97 💬 |
342 |
Coamoxiclav |
- |
- |
- |
- |
097 [1] 97 💬 |
343 |
Cobitolimod |
Cobitolimod |
- |
- |
- |
097 [1] 97 💬 |
344 |
Coffee |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
345 |
Coffee coal |
- |
- |
- |
- |
097 [1] 97 💬 |
346 |
Colal pred |
- |
- |
- |
- |
097 [1] 97 💬 |
347 |
Colal-pred |
- |
- |
- |
- |
097 [1] 97 💬 |
348 |
Colal-pred® |
- |
- |
- |
- |
097 [1] 97 💬 |
349 |
Colazide |
- |
- |
- |
- |
097 [1] 97 💬 |
350 |
Coltect |
- |
- |
- |
- |
097 [1] 97 💬 |
351 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
[2] D00088 D00088, D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
352 |
Combination product: beclomethasone dipropionate in addition to mc-evoo |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
353 |
Combination product: beclomethasone dipropionate in addition to refined oil |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
354 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
355 |
Corticosteroid |
- |
- |
- |
- |
013 [10] 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
356 |
Corticosteroids |
- |
- |
- |
- |
041 [10] 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬 |
357 |
Corticosteroids only |
- |
- |
- |
- |
097 [1] 97 💬 |
358 |
Cortimentmmx 9 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
359 |
Cosmofer |
- |
- |
- |
- |
086 [3] 86, 96, 97 💬 |
360 |
Cosmofer 50mg/ml solution for infusion or injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
361 |
Cotrimoxazole |
- |
- |
- |
- |
085 [2] 85, 97 💬 |
362 |
Cp |
- |
- |
- |
- |
006 [6] 6 , 46, 96, 97, 107, 271 💬 |
363 |
Cp- 690 550 |
- |
- |
- |
- |
097 [1] 97 💬 |
364 |
Cp-690,500 5 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
365 |
Cp-690,550 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
366 |
Cp-690,550 10 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
367 |
Cp-690,550-10 |
- |
- |
- |
- |
046 [5] 46, 96, 97, 107, 271 💬 |
368 |
Cp690,550 |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
369 |
Cs (corticosteroids) only |
- |
- |
- |
- |
097 [1] 97 💬 |
370 |
Ct-p13 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
371 |
Ct-p13 sc (infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
372 |
Curcumin |
Curcumin |
- |
- |
- |
002 [11] 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
373 |
Cyclosporin |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 [17] 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
374 |
Cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [35] 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
375 |
Cyclosporine (usan) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
376 |
Cyclosporine vs infliximab |
Cyclosporine |
[2] D00184 D00184, D02598 D02598 💬 |
PPP3CA [6] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [84] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway |
097 [1] 97 💬 |
377 |
Cycol |
- |
- |
- |
- |
097 [1] 97 💬 |
378 |
Cycol™ |
- |
- |
- |
- |
097 [1] 97 💬 |
379 |
Cytochrome p450 (cyp) substrates |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
380 |
D-proline |
D-Proline |
[1] D00035 D00035 💬 |
- |
- |
097 [1] 97 💬 |
381 |
Daclizumab |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [7] 13, 56, 60, 65, 97, 283, 284 💬 |
382 |
Dacortin |
- |
- |
- |
- |
097 [1] 97 💬 |
383 |
Dand (14-deoxyandrographolide) |
- |
- |
- |
- |
097 [1] 97 💬 |
384 |
Ddand (14-deoxy-11,12-didehydroandrographolide) |
- |
- |
- |
- |
097 [1] 97 💬 |
385 |
Decortin h |
- |
- |
- |
- |
066 [3] 66, 97, 145 💬 |
386 |
Decortin h 1 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
387 |
Decortin h 10mg |
- |
- |
- |
- |
097 [1] 97 💬 |
388 |
Decortin h 20mg |
- |
- |
- |
- |
097 [1] 97 💬 |
389 |
Decortin h 50 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
390 |
Decortin h 5mg |
- |
- |
- |
- |
097 [1] 97 💬 |
391 |
Dekavil |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
392 |
Dekristol |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
393 |
Delayed and extended release mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
394 |
Deligoparin |
- |
- |
- |
- |
097 [1] 97 💬 |
395 |
Delmitide acetate |
Acetate |
- |
- |
- |
097 [1] 97 💬 |
396 |
Deltacortene |
- |
- |
- |
- |
043 [2] 43, 97 💬 |
397 |
Deltacortene 10 cpr 25mg |
- |
- |
- |
- |
097 [1] 97 💬 |
398 |
Deltacortene 20 cpr 5mg |
- |
- |
- |
- |
097 [1] 97 💬 |
399 |
Deltacortene forte*10cpr 25mg |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
400 |
Deltacortene*20cpr 5mg |
- |
- |
- |
- |
049 [3] 49, 97, 113 💬 |
401 |
Dersalazina sodica |
- |
- |
- |
- |
097 [1] 97 💬 |
402 |
Dersalazine |
Dersalazine |
- |
- |
- |
097 [1] 97 💬 |
403 |
Dersalazine sodium |
Dersalazine |
- |
- |
- |
097 [1] 97 💬 |
404 |
Device: the colonic transendoscopic enteral tubing. |
- |
- |
- |
- |
097 [1] 97 💬 |
405 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
406 |
Dexamethasone 21-phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
407 |
Dextran |
Dextran |
[1] D00060 D00060 💬 |
- |
- |
002 [5] 2 , 62, 79, 96, 97 💬 |
408 |
Dextran 1 for injection |
Dextran |
[1] D00060 D00060 💬 |
- |
- |
097 [1] 97 💬 |
409 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
410 |
Dextromethorphan 30 mg |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 [2] 96, 97 💬 |
411 |
Diagnostic test: antibodies to golimumab |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
412 |
Diagnostic test: calprotectin |
- |
- |
- |
- |
097 [1] 97 💬 |
413 |
Diagnostic test: colonoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
414 |
Diagnostic test: golimumab trough levels |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
415 |
Diagnostic test: histology |
- |
- |
- |
- |
097 [1] 97 💬 |
416 |
Diagnostic test: parasitological diagnostics (coproscopy) |
- |
- |
- |
- |
097 [1] 97 💬 |
417 |
Diagnostic test: rectosigmoidoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
418 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
096 [2] 96, 97 💬 |
419 |
Diet |
- |
- |
- |
- |
097 [3] 97, 240, 299 💬 |
420 |
Dims0150 |
- |
- |
- |
- |
097 [1] 97 💬 |
421 |
Doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 [15] 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
422 |
Dukoral |
- |
- |
- |
- |
097 [1] 97 💬 |
423 |
E. coli nissle |
- |
- |
- |
- |
097 [1] 97 💬 |
424 |
E6007 |
- |
- |
- |
- |
097 [1] 97 💬 |
425 |
Ecologic 825 |
- |
- |
- |
- |
097 [1] 97 💬 |
426 |
Egf enema |
- |
- |
- |
- |
097 [1] 97 💬 |
427 |
Eicosapentaenoic acid |
Icosapent |
[1] D08061 D08061 💬 |
- |
- |
049 [5] 49, 96, 97, 296, 297 💬 |
428 |
Emea/h/c/000240 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
429 |
Emea/h/c/000481 |
- |
- |
- |
- |
097 [1] 97 💬 |
430 |
En |
- |
- |
- |
- |
006 [3] 6 , 46, 97 💬 |
431 |
Encapsulated faecal microbiota |
- |
- |
- |
- |
097 [1] 97 💬 |
432 |
Encapsulated faecal microbiota filtrate |
- |
- |
- |
- |
097 [1] 97 💬 |
433 |
Encapsulated mesalamine granules (emg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
434 |
Entecavir |
Entecavir |
[2] D04008 D04008, D07896 D07896 💬 |
- |
- |
046 [5] 46, 56, 96, 97, 271 💬 |
435 |
Entocort cr |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
436 |
Entocort ec® 3 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
437 |
Entocort® cr |
- |
- |
- |
- |
097 [1] 97 💬 |
438 |
Entyvio |
- |
- |
- |
- |
094 [3] 94, 96, 97 💬 |
439 |
Entyvio 300 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
440 |
Entyvio 300mg |
- |
- |
- |
- |
097 [1] 97 💬 |
441 |
Epaxal berna (virosomal hepatitis a vaccine) |
Hepatitis A Vaccine |
- |
- |
- |
096 [2] 96, 97 💬 |
442 |
Epidermal growth factor |
- |
- |
- |
- |
097 [1] 97 💬 |
443 |
Epidermal growth factor enema |
- |
- |
- |
- |
097 [1] 97 💬 |
444 |
Ergocalciferol |
Ergocalciferol |
[1] D00187 D00187 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 [5] 46, 84, 96, 97, 299 💬 |
445 |
Ethanol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 [4] 51, 97, 279, 280 💬 |
446 |
Etrasimod |
Etrasimod |
[1] D10930 D10930 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 [2] 96, 97 💬 |
447 |
Etrasimod l-arginine |
Arginine |
[2] D02982 D02982, D10930 D10930 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 [2] 96, 97 💬 |
448 |
Etrolizumab |
Etrolizumab |
[1] D09901 D09901 💬 |
ITGB7 [1] ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [11] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer |
096 [2] 96, 97 💬 |
449 |
Etrozulimab |
- |
- |
- |
- |
097 [1] 97 💬 |
450 |
Exposure to golimumab |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
451 |
F8il10 |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
452 |
Factor xiii |
Factor XIII (human) |
- |
- |
- |
051 [3] 51, 97, 288 💬 |
453 |
Faecal matter |
- |
- |
- |
- |
097 [1] 97 💬 |
454 |
Faecal microbiota transplant |
- |
- |
- |
- |
097 [1] 97 💬 |
455 |
Faecal microbiota transplantation |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
456 |
Fe 999301 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
457 |
Fecal microbial transplant |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
458 |
Fecal microbial transplantation |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
459 |
Fecal microbiota |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
460 |
Fecal microbiota capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
461 |
Fecal microbiota enema |
- |
- |
- |
- |
097 [1] 97 💬 |
462 |
Fecal microbiota transplant |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
463 |
Fecal microbiota transplant (fmt) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
464 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 [5] 2 , 66, 94, 96, 97 💬 |
465 |
Fecal microbiota transplantation (fmt) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
466 |
Fecal microbiota transplantation (fmt), openbiome |
- |
- |
- |
- |
097 [1] 97 💬 |
467 |
Ferric carboxymaltose |
Ferric carboxymaltose |
[1] D08920 D08920 💬 |
- |
- |
086 [4] 86, 96, 97, 299 💬 |
468 |
Ferrous sulphate |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
469 |
Filgotinib |
Filgotinib |
[1] D10871 D10871 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [6] 46, 53, 96, 97, 222, 271 💬 |
470 |
Film-coated tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
471 |
Fitc-adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
472 |
Flagyl |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
473 |
Flaxseed |
- |
- |
- |
- |
097 [2] 97, 299 💬 |
474 |
Flaxseed lignan-enriched complex (flc) |
- |
- |
- |
- |
097 [1] 97 💬 |
475 |
Flixabi |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
476 |
Fluorescein |
Fluorescein |
[2] D01261 D01261, D02024 D02024 💬 |
- |
- |
019 [2] 19, 97 💬 |
477 |
Flupentixol |
Flupentixol |
[1] D01044 D01044 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
097 [1] 97 💬 |
478 |
Fmt |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
479 |
Fmt enema |
- |
- |
- |
- |
097 [1] 97 💬 |
480 |
Fmt infusions |
- |
- |
- |
- |
097 [1] 97 💬 |
481 |
Fmt oral |
- |
- |
- |
- |
097 [1] 97 💬 |
482 |
Fosfomycin |
Fosfomycin |
[4] D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253 💬 |
- |
- |
096 [2] 96, 97 💬 |
483 |
Fp-110 |
- |
- |
- |
- |
097 [1] 97 💬 |
484 |
Fp-cya-050 |
- |
- |
- |
- |
097 [1] 97 💬 |
485 |
Fp-cya-053 |
- |
- |
- |
- |
097 [1] 97 💬 |
486 |
Freeze-dried black raspberry powder |
Raspberry |
- |
- |
- |
097 [1] 97 💬 |
487 |
G321605 |
- |
- |
- |
- |
085 [3] 85, 96, 97 💬 |
488 |
Ganciclovir |
Ganciclovir |
[2] D00333 D00333, D04301 D04301 💬 |
- |
- |
028 [3] 28, 60, 97 💬 |
489 |
Gastro-resistant phosphatidylcholine granules |
Lecithin |
[1] D04682 D04682 💬 |
- |
- |
097 [1] 97 💬 |
490 |
Gb004 |
- |
- |
- |
- |
097 [1] 97 💬 |
491 |
Ged-0301 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
492 |
Ged-0507-34-levo |
GED-0507-34-Levo |
- |
- |
- |
097 [1] 97 💬 |
493 |
Ged-0507-34-levo 160 mg |
GED-0507-34-Levo |
- |
- |
- |
097 [1] 97 💬 |
494 |
Ged-0507-34-levo 80 mg |
GED-0507-34-Levo |
- |
- |
- |
097 [1] 97 💬 |
495 |
Ged0507 |
- |
- |
- |
- |
097 [1] 97 💬 |
496 |
Gelatin |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
028 [4] 28, 78, 97, 269 💬 |
497 |
Genetic: tpmt genotyping |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
498 |
Gi-270384 |
- |
- |
- |
- |
097 [1] 97 💬 |
499 |
Gliolan |
- |
- |
- |
- |
097 [1] 97 💬 |
500 |
Glpg0974 |
- |
- |
- |
- |
097 [1] 97 💬 |
501 |
Glpg1205 |
- |
- |
- |
- |
085 [3] 85, 96, 97 💬 |
502 |
Glpg3970 |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
503 |
Glutamine |
L-Glutamine |
[1] D00015 D00015 💬 |
- |
- |
087 [7] 87, 89, 96, 97, 113, 245, 299 💬 |
504 |
Glycyrrhiza |
Glycyrrhiza glabra |
- |
- |
- |
053 [2] 53, 97 💬 |
505 |
Glycyrrhiza glabra |
Glycyrrhiza glabra |
- |
- |
- |
097 [1] 97 💬 |
506 |
Glycyrrhiza glabra root |
Glycyrrhiza glabra |
- |
- |
- |
097 [1] 97 💬 |
507 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
508 |
Golimumab |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [6] 46, 56, 84, 96, 97, 271 💬 |
509 |
Golimumab (glm) |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
510 |
Golimumab (optimization) |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
511 |
Golimumab 1 mg per kg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
512 |
Golimumab 100 mg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 97 💬 |
513 |
Golimumab 2 mg per kg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
514 |
Golimumab 200 mg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
515 |
Golimumab 4 mg per kg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
516 |
Golimumab 400 mg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
517 |
Golimumab 50 mg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [2] 46, 97 💬 |
518 |
Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
519 |
Golimumab dose 1 |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
520 |
Golimumab dose 2 |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
521 |
Golimumab liquid in prefilled syringe |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 84, 97 💬 |
522 |
Golimumab liquid in vial |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 97, 271 💬 |
523 |
Golimumab prefilled syringe |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
524 |
Golimumab treatment optimization. |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
525 |
Gralise |
- |
- |
- |
- |
097 [2] 97, 226 💬 |
526 |
Granulated mesalamine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
527 |
Grapefruit |
Grapefruit |
- |
- |
- |
006 [5] 6 , 46, 50, 83, 97 💬 |
528 |
Group 1- control diet |
- |
- |
- |
- |
097 [1] 97 💬 |
529 |
Group 2- ucd diet |
- |
- |
- |
- |
097 [1] 97 💬 |
530 |
Gs-4875 |
- |
- |
- |
- |
097 [1] 97 💬 |
531 |
Gs-5745 |
GS-5745 |
- |
- |
- |
046 [4] 46, 96, 97, 299 💬 |
532 |
Gs-5745 iv |
GS-5745 |
- |
- |
- |
097 [1] 97 💬 |
533 |
Gs-5745 sc |
GS-5745 |
- |
- |
- |
097 [1] 97 💬 |
534 |
Gs-6034 |
- |
- |
- |
- |
046 [4] 46, 53, 96, 97 💬 |
535 |
Gsk1399686 |
- |
- |
- |
- |
097 [1] 97 💬 |
536 |
Gsk1605786 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
537 |
Gsk1605786a |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
538 |
Gsk2586184 400mg |
- |
- |
- |
- |
097 [1] 97 💬 |
539 |
Gsk2831781 |
- |
- |
- |
- |
097 [1] 97 💬 |
540 |
Gsk2831781 iv infusion |
- |
- |
- |
- |
097 [1] 97 💬 |
541 |
Gsk2831781 sc injection |
- |
- |
- |
- |
097 [1] 97 💬 |
542 |
Gsk2982772 |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
543 |
Gsk2982772a, where a denotes the free base |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
544 |
Guaiazulene |
Guaiazulen |
- |
- |
- |
097 [1] 97 💬 |
545 |
Guselkum |
- |
- |
- |
- |
097 [1] 97 💬 |
546 |
Guselkumab |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 [4] 37, 41, 96, 97 💬 |
547 |
Guselkumab dose 1 |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
548 |
Guselkumab dose 2 |
Guselkumab |
[1] D10438 D10438 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
549 |
Gwp42003 |
- |
- |
- |
- |
097 [1] 97 💬 |
550 |
H02ab |
- |
- |
- |
- |
097 [1] 97 💬 |
551 |
He3286 |
HE3286 |
- |
- |
- |
046 [2] 46, 97 💬 |
552 |
Hemay007 |
- |
- |
- |
- |
097 [1] 97 💬 |
553 |
Hepatitis a vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
554 |
Herbal treatment (sa100) |
- |
- |
- |
- |
097 [1] 97 💬 |
555 |
Hextend |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
556 |
Hf2 |
- |
- |
- |
- |
097 [1] 97 💬 |
557 |
Hgd40 |
- |
- |
- |
- |
097 [1] 97 💬 |
558 |
Hgs1025 |
- |
- |
- |
- |
097 [1] 97 💬 |
559 |
High dose |
- |
- |
- |
- |
097 [1] 97 💬 |
560 |
High dose budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
561 |
Hmpl-004 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
562 |
Hmpl-004 1800 mg/day |
- |
- |
- |
- |
097 [1] 97 💬 |
563 |
Hmpl-004 2400 mg/day |
- |
- |
- |
- |
097 [1] 97 💬 |
564 |
Hmpl-004 high dose |
- |
- |
- |
- |
097 [1] 97 💬 |
565 |
Hmpl-004 low dose |
- |
- |
- |
- |
097 [1] 97 💬 |
566 |
Hmpl004-6599 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
567 |
Hulio |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
568 |
Hum291 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
569 |
Hum291) |
- |
- |
- |
- |
097 [1] 97 💬 |
570 |
Human anti-ip10 monoclonal antibody |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
571 |
Human anti-tnf igg1 monoclonal antibody |
- |
- |
- |
- |
046 [3] 46, 97, 271 💬 |
572 |
Human anti-tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
573 |
Human anti-tnfalfa |
- |
- |
- |
- |
046 [3] 46, 97, 271 💬 |
574 |
Humanized recombinant igg4 monoclonal antibody against cd-127 |
- |
- |
- |
- |
097 [1] 97 💬 |
575 |
Humira |
- |
- |
- |
- |
046 [7] 46, 84, 96, 97, 160, 269, 271 💬 |
576 |
Humira (adalimumab original) |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
577 |
Humira 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
578 |
Humira 40 mg solution for injection in pre-filled syringes |
- |
- |
- |
- |
097 [1] 97 💬 |
579 |
Humira 40 mg/0.8 ml solution for injection |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
580 |
Humira 40 mg/0.8 ml solution for injection for paediatric use |
- |
- |
- |
- |
097 [1] 97 💬 |
581 |
Humira 40mg solution for injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
582 |
Humira ® |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
583 |
Humira® |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
584 |
Hyaluronate |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
053 [2] 53, 97 💬 |
585 |
Hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [9] 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
586 |
Hydrocortisone acetate |
Acetate |
[2] D00088 D00088, D00165 D00165 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
587 |
Hydrocortisone sodium succinate |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [3] 81, 83, 97 💬 |
588 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 [7] 5 , 6 , 13, 17, 83, 97, 226 💬 |
589 |
Hydroxide |
Hydroxide ion |
- |
- |
- |
046 [4] 46, 96, 97, 284 💬 |
590 |
Hydroxocobalamin |
Hydroxocobalamin |
[3] D01027 D01027, D02707 D02707, D04929 D04929 💬 |
- |
- |
097 [1] 97 💬 |
591 |
Hydroxocobalamin with butyrate |
Butyric Acid |
[4] D01027 D01027, D02707 D02707, D04929 D04929, D05866 D05866 💬 |
- |
- |
097 [1] 97 💬 |
592 |
Ibd98-m |
- |
- |
- |
- |
097 [1] 97 💬 |
593 |
Ibd98-m delayed-release capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
594 |
Iberogast n |
- |
- |
- |
- |
097 [1] 97 💬 |
595 |
Idoform®travel |
- |
- |
- |
- |
097 [1] 97 💬 |
596 |
Im90838 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
597 |
Imolope |
- |
- |
- |
- |
097 [1] 97 💬 |
598 |
Impact |
- |
- |
- |
- |
006 [8] 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
599 |
Imu-838 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
600 |
Imuran |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
601 |
Imurek |
- |
- |
- |
- |
097 [1] 97 💬 |
602 |
Imurek 25mg filmtabletten |
- |
- |
- |
- |
097 [1] 97 💬 |
603 |
Imurek 50mg filmtabletten |
- |
- |
- |
- |
097 [1] 97 💬 |
604 |
Imurel |
- |
- |
- |
- |
013 [4] 13, 46, 96, 97 💬 |
605 |
Incb039110 |
- |
- |
- |
- |
051 [2] 51, 97 💬 |
606 |
Inflectra |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
607 |
Inflectra 100 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
608 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
609 |
Infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 [24] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
610 |
Infliximab (ifx) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
611 |
Infliximab 10 mg/kg |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
612 |
Infliximab 5 mg/kg |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
613 |
Infliximab [infliximab biosimilar 3] |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 [4] 37, 46, 96, 97 💬 |
614 |
Infliximab and adalimumab |
Adalimumab |
[2] D02597 D02597, D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
615 |
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab |
Adalimumab |
[5] D02597 D02597, D02598 D02598, D04358 D04358, D08083 D08083, D09214 D09214 💬 |
IL12A [6] IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
616 |
Infliximab, adalimumab, certolizumab pegol |
Adalimumab |
[3] D02597 D02597, D02598 D02598, D03441 D03441 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
617 |
Innovator infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
618 |
Inositol |
Inositol |
[1] D08079 D08079 💬 |
- |
- |
096 [2] 96, 97 💬 |
619 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 [5] 13, 20, 26, 96, 97 💬 |
620 |
Interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [4] 13, 26, 96, 97 💬 |
621 |
Interferon-beta |
Human interferon beta |
- |
- |
- |
013 [2] 13, 97 💬 |
622 |
Interferon-beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [2] 13, 97 💬 |
623 |
Interferon-beta-1a, 44 microgram |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
097 [1] 97 💬 |
624 |
Interferon-beta-1a, 66 microgram |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
097 [1] 97 💬 |
625 |
Interleukin 2 |
- |
- |
- |
- |
046 [9] 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
626 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 [8] 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
627 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 [2] 96, 97 💬 |
628 |
Iron |
Iron |
- |
- |
- |
018 [5] 18, 96, 97, 254, 284 💬 |
629 |
Iron sucrose |
Iron |
[2] D00025 D00025, D04616 D04616 💬 |
- |
- |
062 [3] 62, 96, 97 💬 |
630 |
Iron sulphate |
Iron |
- |
- |
- |
096 [2] 96, 97 💬 |
631 |
Iron sulphate 200mg coated tablets |
Iron |
- |
- |
- |
096 [2] 96, 97 💬 |
632 |
Iron supplement 300-600 mg/day |
Iron |
- |
- |
- |
096 [2] 96, 97 💬 |
633 |
Iron(iii)- hydroxide dextran complex |
Dextran |
[1] D00060 D00060 💬 |
- |
- |
096 [2] 96, 97 💬 |
634 |
Itacitinib |
Itacitinib |
[1] D10944 D10944 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [5] 46, 51, 60, 97, 228 💬 |
635 |
Itacitinib adipate |
Iron (III) oxide adipate |
[1] D10944 D10944 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [2] 97, 228 💬 |
636 |
Iv corticosteroid |
- |
- |
- |
- |
097 [1] 97 💬 |
637 |
Jnj-54781532 150 mg once daily |
- |
- |
- |
- |
097 [1] 97 💬 |
638 |
Jnj-54781532 25 mg once daily |
- |
- |
- |
- |
097 [1] 97 💬 |
639 |
Jnj-54781532 75 mg once daily |
- |
- |
- |
- |
097 [1] 97 💬 |
640 |
Jnj-54781532 75 mg twice daily |
- |
- |
- |
- |
097 [1] 97 💬 |
641 |
Jnj-54781532-aad-10 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
642 |
Jnj-54781532-aad-30 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
643 |
Jnj-54781532-aad-5 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
644 |
Jnj-66525433 |
- |
- |
- |
- |
097 [1] 97 💬 |
645 |
K(d)pt |
- |
- |
- |
- |
097 [1] 97 💬 |
646 |
Kamillenblüten 3ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
647 |
Kappaproct |
- |
- |
- |
- |
097 [1] 97 💬 |
648 |
Kdpt |
- |
- |
- |
- |
097 [1] 97 💬 |
649 |
Khk4083 |
- |
- |
- |
- |
097 [1] 97 💬 |
650 |
Kremezin |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
651 |
Kremezin®, spherical adsorptive carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
096 [2] 96, 97 💬 |
652 |
Krp203 |
- |
- |
- |
- |
097 [1] 97 💬 |
653 |
Krp203a |
- |
- |
- |
- |
097 [1] 97 💬 |
654 |
Kyo-dophilus |
- |
- |
- |
- |
097 [1] 97 💬 |
655 |
Kümmel 2ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
656 |
L-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 [6] 13, 96, 97, 265, 298, 316 💬 |
657 |
L-lysyl-d-prolyl-l-threonine acetate |
Acetate |
[1] D00041 D00041 💬 |
- |
- |
097 [1] 97 💬 |
658 |
L-lysyl-d-prolyl-lthreonine acetate, lyophilisate |
Acetate |
- |
- |
- |
097 [1] 97 💬 |
659 |
Lactated ringers |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
660 |
Lactobacillus casei dg |
- |
- |
- |
- |
097 [1] 97 💬 |
661 |
Lactobacillus gg |
- |
- |
- |
- |
097 [1] 97 💬 |
662 |
Lactobacillus plantarum |
Lactobacillus plantarum |
- |
- |
- |
006 [3] 6 , 97, 156 💬 |
663 |
Lactobacillus reuteri |
Lactobacillus reuteri |
- |
- |
- |
097 [2] 97, 299 💬 |
664 |
Lactobacillus rhamnosus gg atcc 53103 |
- |
- |
- |
- |
097 [1] 97 💬 |
665 |
Lactobacillus salivarius ucc118 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
666 |
Lactobacilus acidophilus & bifidobacterium animalis/lactis |
Lactobacillus acidophilus |
[1] D04349 D04349 💬 |
- |
- |
097 [1] 97 💬 |
667 |
Lactose |
Lactose |
[2] D00046 D00046, D03226 D03226 💬 |
- |
- |
002 [6] 2 , 6 , 13, 97, 228, 310 💬 |
668 |
Lactose in water |
Lactose |
[3] D00001 D00001, D00046 D00046, D03226 D03226 💬 |
- |
- |
097 [1] 97 💬 |
669 |
Lc51-0255 |
- |
- |
- |
- |
097 [1] 97 💬 |
670 |
Ldp-02 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
671 |
Leucine |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
005 [10] 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
672 |
Levocarnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 [3] 3 , 53, 97 💬 |
673 |
Levocarnitine propyl hydrochloride |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
674 |
Linaclotide |
Linaclotide |
[1] D09355 D09355 💬 |
GUCY2C [1] GUCY2C 💬 |
Metabolic pathways [2] Metabolic pathways, Purine metabolism |
097 [1] 97 💬 |
675 |
Lixacol |
- |
- |
- |
- |
097 [1] 97 💬 |
676 |
Loperamide |
Loperamide |
[3] D00729 D00729, D07113 D07113, D08144 D08144 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 [2] 13, 97 💬 |
677 |
Loperamide hydrochloride |
Loperamide |
[3] D00729 D00729, D07113 D07113, D08144 D08144 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
678 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
679 |
Low dose |
- |
- |
- |
- |
097 [1] 97 💬 |
680 |
Low dose budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
681 |
Low dose naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
096 [2] 96, 97 💬 |
682 |
Low fodmap |
- |
- |
- |
- |
097 [1] 97 💬 |
683 |
Lt-02 |
- |
- |
- |
- |
097 [1] 97 💬 |
684 |
Lt-02 (modified-release pc pellets) |
- |
- |
- |
- |
097 [1] 97 💬 |
685 |
Lumbar puncture |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
686 |
Lx1606 |
- |
- |
- |
- |
097 [1] 97 💬 |
687 |
Ly3074828 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
688 |
Lyc-30937 |
- |
- |
- |
- |
097 [1] 97 💬 |
689 |
Lyc-30937-ec |
- |
- |
- |
- |
097 [1] 97 💬 |
690 |
Lys006 |
- |
- |
- |
- |
097 [1] 97 💬 |
691 |
Lysine |
L-Lysine |
[1] D02304 D02304 💬 |
- |
- |
013 [4] 13, 97, 228, 299 💬 |
692 |
Lysine-d-proline-threonine |
D-Proline |
[3] D00035 D00035, D00041 D00041, D02304 D02304 💬 |
- |
- |
097 [1] 97 💬 |
693 |
Magnesium |
Magnesium |
- |
- |
- |
006 [16] 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
694 |
Magnesium citrate |
Magnesium |
[1] D03265 D03265 💬 |
- |
- |
097 [1] 97 💬 |
695 |
Maltodextrin |
Maltodextrin |
[1] D02329 D02329 💬 |
- |
- |
006 [4] 6 , 13, 96, 97 💬 |
696 |
Maltose |
Maltose |
[1] D00044 D00044 💬 |
- |
- |
096 [2] 96, 97 💬 |
697 |
Mango |
Mango |
- |
- |
- |
096 [2] 96, 97 💬 |
698 |
Mango polyphenolics |
Mango |
- |
- |
- |
096 [2] 96, 97 💬 |
699 |
Mare´s milk |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
700 |
Matricaria flower |
Chamomile |
[1] D09212 D09212 💬 |
- |
- |
097 [1] 97 💬 |
701 |
Matricaria recutita l. flos |
- |
- |
- |
- |
097 [1] 97 💬 |
702 |
Maximal oral 5asa |
- |
- |
- |
- |
097 [1] 97 💬 |
703 |
Md-0901 |
- |
- |
- |
- |
097 [1] 97 💬 |
704 |
Mdx-1100 |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
705 |
Mdx-1100 (anti-cxcl10 human monoclonal antibody) |
- |
- |
- |
- |
097 [1] 97 💬 |
706 |
Medi7183 high dose |
- |
- |
- |
- |
097 [1] 97 💬 |
707 |
Medi7183 low dose |
- |
- |
- |
- |
097 [1] 97 💬 |
708 |
Medi7183 medium dose |
- |
- |
- |
- |
097 [1] 97 💬 |
709 |
Melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [11] 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
710 |
Melissae folii dry aqueous extract |
- |
- |
- |
- |
097 [1] 97 💬 |
711 |
Melissenblätter 15ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
712 |
Melitracen |
Melitracen |
[1] D08171 D08171 💬 |
- |
- |
097 [1] 97 💬 |
713 |
Mentha × piperita l. folium |
- |
- |
- |
- |
097 [1] 97 💬 |
714 |
Mercaptopurine |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 [3] 96, 97, 164 💬 |
715 |
Mercaptopurine (puri-nethol) |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 [1] 97 💬 |
716 |
Mercaptopurine (purinethol) |
Mercaptopurine |
[2] D00161 D00161, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 [1] 97 💬 |
717 |
Mesalamin |
- |
- |
- |
- |
097 [1] 97 💬 |
718 |
Mesalamine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [3] 96, 97, 164 💬 |
719 |
Mesalamine delayed release tablets 400mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
720 |
Mesalamine enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
721 |
Mesalamine granules |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
722 |
Mesalamine once-daily |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
723 |
Mesalamine twice-daily |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
724 |
Mesalamine, 5-aminosalicylic acid [5-asa] |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
725 |
Mesalamine, 5-asa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
726 |
Mesalazina |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
727 |
Mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
046 [3] 46, 96, 97 💬 |
728 |
Mesalazine (3,600 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
729 |
Mesalazine (asacol®) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
730 |
Mesalazine - tid 1000 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
731 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
732 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
733 |
Mesalazine 250mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
734 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
[2] D00377 D00377, D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
735 |
Mesalazine 4g enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
736 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
737 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
738 |
Mesalazine enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
739 |
Mesalazine liquid enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
740 |
Mesalazine slow-release granules |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
741 |
Mesalazine tablet |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
742 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
[2] D00088 D00088, D00377 D00377 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
743 |
Mesalazinum |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
744 |
Mesenchymal cells |
- |
- |
- |
- |
097 [1] 97 💬 |
745 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 [9] 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
746 |
Met-2 |
- |
- |
- |
- |
097 [1] 97 💬 |
747 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
748 |
Methotrexate bellon |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 [1] 97 💬 |
749 |
Methotrexate bellon 25mg/ml |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 [1] 97 💬 |
750 |
Methotrexate disodium |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [3] 46, 96, 97 💬 |
751 |
Methotrexate injection |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 [2] 96, 97 💬 |
752 |
Methylene blue |
Methylene blue |
[2] D02312 D02312, D10537 D10537 💬 |
- |
- |
097 [1] 97 💬 |
753 |
Methylene blue 25mg tablets |
Methylene blue |
[2] D02312 D02312, D10537 D10537 💬 |
- |
- |
097 [1] 97 💬 |
754 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
755 |
Methylprednisolone sodium hemisuccinate |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
756 |
Metoject |
- |
- |
- |
- |
041 [4] 41, 46, 96, 97 💬 |
757 |
Metronidazole |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 [8] 46, 51, 63, 94, 95, 96, 97, 291 💬 |
758 |
Metronidazole capsule 50 mg |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
097 [1] 97 💬 |
759 |
Mezavant |
- |
- |
- |
- |
097 [1] 97 💬 |
760 |
Mezavant 1200 mg magensaftresistente retardtabletten |
- |
- |
- |
- |
097 [1] 97 💬 |
761 |
Mezavant gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
762 |
Mezavant xl |
- |
- |
- |
- |
097 [1] 97 💬 |
763 |
Mezavant xl 1200 mg gastro-resistant prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
764 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
765 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets. |
- |
- |
- |
- |
097 [1] 97 💬 |
766 |
Mezavant xl 1200mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
767 |
Mezavant xl gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
768 |
Midazolam |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
769 |
Midazolam 2 mg |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
096 [2] 96, 97 💬 |
770 |
Mirikizumab |
Mirikizumab |
[1] D11123 D11123 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 [3] 37, 96, 97 💬 |
771 |
Mirikizumab iv |
Mirikizumab |
[1] D11123 D11123 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
097 [1] 97 💬 |
772 |
Mirikizumab sc |
Mirikizumab |
[1] D11123 D11123 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
097 [1] 97 💬 |
773 |
Mitoq |
- |
- |
- |
- |
006 [3] 6 , 13, 97 💬 |
774 |
Mk-8259 |
- |
- |
- |
- |
097 [1] 97 💬 |
775 |
Mln0002 |
- |
- |
- |
- |
094 [3] 94, 96, 97 💬 |
776 |
Mln0002 (vedolizumab) |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
777 |
Mln0002 sc |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
778 |
Mln002 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
779 |
Mmx mesalamine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
780 |
Mmx mesalamine/ mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
781 |
Mmx mesalamine/mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
782 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
783 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
784 |
Modified gegen qinlian decoction |
- |
- |
- |
- |
097 [1] 97 💬 |
785 |
Modified-release phosphatidylcholine |
Lecithin |
[1] D04682 D04682 💬 |
- |
- |
097 [1] 97 💬 |
786 |
Mongersen |
Mongersen |
[1] D10956 D10956 💬 |
SMAD7 [1] SMAD7 💬 |
Hippo signaling pathway [2] Hippo signaling pathway, TGF-beta signaling pathway |
096 [2] 96, 97 💬 |
787 |
Monoclonal antibody anti-igg1 |
- |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
788 |
Msc |
- |
- |
- |
- |
006 [6] 6 , 51, 60, 96, 97, 271 💬 |
789 |
Mtx |
- |
- |
- |
- |
035 [12] 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
790 |
Mtx 12.5 |
- |
- |
- |
- |
097 [1] 97 💬 |
791 |
Mtx 25 |
- |
- |
- |
- |
097 [1] 97 💬 |
792 |
Multiple dose- group b |
- |
- |
- |
- |
097 [1] 97 💬 |
793 |
Multiple dose-group b |
- |
- |
- |
- |
097 [1] 97 💬 |
794 |
Multistem |
MultiStem |
- |
- |
- |
097 [1] 97 💬 |
795 |
Multistem high dose |
MultiStem |
- |
- |
- |
097 [1] 97 💬 |
796 |
Multistem low dose |
MultiStem |
- |
- |
- |
097 [1] 97 💬 |
797 |
Mycodigest supplement |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
798 |
Myrrh |
Myrrh |
[1] D08948 D08948 💬 |
- |
- |
097 [1] 97 💬 |
799 |
Myrrhinil-intest® |
- |
- |
- |
- |
097 [1] 97 💬 |
800 |
N.a. |
- |
- |
- |
- |
003 [10] 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
801 |
Naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [12] 6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 |
802 |
Nand (neoandrographolide) |
- |
- |
- |
- |
097 [1] 97 💬 |
803 |
Nanocort |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
804 |
Nd |
- |
- |
- |
- |
013 [4] 13, 46, 51, 97 💬 |
805 |
Neomycin |
Neomycin |
[1] D08260 D08260 💬 |
- |
- |
096 [3] 96, 97, 296 💬 |
806 |
Neoral |
- |
- |
- |
- |
060 [3] 60, 97, 222 💬 |
807 |
Neoral soft gelatin capsules |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [2] 97, 269 💬 |
808 |
Niclosamide |
Niclosamide |
[1] D00436 D00436 💬 |
- |
- |
046 [2] 46, 97 💬 |
809 |
Nicolon |
- |
- |
- |
- |
097 [1] 97 💬 |
810 |
Nitazoxanide |
Nitazoxanide |
[1] D02486 D02486 💬 |
- |
- |
096 [2] 96, 97 💬 |
811 |
Nitazoxanide 500mg oral tablet |
Nitazoxanide |
[1] D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
812 |
Nivolumab |
Nivolumab |
[1] D10316 D10316 💬 |
PDCD1 [1] PDCD1 💬 |
Cell adhesion molecules [3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
813 |
Nolpitantium besylate |
- |
- |
- |
- |
097 [1] 97 💬 |
814 |
Non as of yet |
- |
- |
- |
- |
097 [1] 97 💬 |
815 |
None |
- |
- |
- |
- |
046 [14] 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
816 |
None given |
- |
- |
- |
- |
097 [1] 97 💬 |
817 |
Normal saline enema |
- |
- |
- |
- |
097 [1] 97 💬 |
818 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
819 |
Nutrition supplement |
- |
- |
- |
- |
097 [1] 97 💬 |
820 |
Nutritional dietary intervention |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
821 |
Nuvion®) |
- |
- |
- |
- |
097 [1] 97 💬 |
822 |
Nx-13 250 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
823 |
Oats |
Oat |
- |
- |
- |
097 [1] 97 💬 |
824 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
825 |
Omeprazole 20 mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 [2] 96, 97 💬 |
826 |
Ondansetron |
Ondansetron |
[2] D00456 D00456, D00678 D00678 💬 |
HTR3A [5] HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse [2] Serotonergic synapse, Taste transduction |
006 [3] 6 , 97, 231 💬 |
827 |
Ondansetron hydrochloride dihydrate |
Ondansetron |
[2] D00456 D00456, D00678 D00678 💬 |
HTR3A [5] HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse [2] Serotonergic synapse, Taste transduction |
006 [2] 6 , 97 💬 |
828 |
Ontamalimab |
Ontamalimab |
- |
- |
- |
096 [2] 96, 97 💬 |
829 |
Opc-6535 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
830 |
Opc-6535 tablets (drug) |
- |
- |
- |
- |
097 [1] 97 💬 |
831 |
Opc-6535(tetomilast) |
Tetomilast |
- |
- |
- |
096 [2] 96, 97 💬 |
832 |
Oprx-106 |
- |
- |
- |
- |
097 [1] 97 💬 |
833 |
Oprx-106 (plant cells expressing tnfr-fc) 2mg |
- |
- |
- |
- |
097 [1] 97 💬 |
834 |
Oprx-106 (plant cells expressing tnfr-fc) 8mg |
- |
- |
- |
- |
097 [1] 97 💬 |
835 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
[7] D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
836 |
Oral corticosteroids |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
837 |
Oral okt3 |
- |
- |
- |
- |
097 [1] 97 💬 |
838 |
Ore1001 |
- |
- |
- |
- |
097 [1] 97 💬 |
839 |
Orencia |
- |
- |
- |
- |
044 [13] 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
840 |
Originator (legacy) drug |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
841 |
Ose-127 |
- |
- |
- |
- |
053 [2] 53, 97 💬 |
842 |
Oseltamivir |
Oseltamivir |
[2] D00900 D00900, D08306 D08306 💬 |
- |
- |
097 [2] 97, 299 💬 |
843 |
Ost-122 |
- |
- |
- |
- |
097 [1] 97 💬 |
844 |
Other: 0 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
845 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
846 |
Other: additional therapies |
- |
- |
- |
- |
097 [1] 97 💬 |
847 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
848 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 [1] 97 💬 |
849 |
Other: conventional drugs |
- |
- |
- |
- |
097 [1] 97 💬 |
850 |
Other: dietary intervention with no-carrageenan diet |
- |
- |
- |
- |
097 [1] 97 💬 |
851 |
Other: e-monitoring |
- |
- |
- |
- |
097 [1] 97 💬 |
852 |
Other: faecal bacterial transplantation |
- |
- |
- |
- |
097 [1] 97 💬 |
853 |
Other: fast mimicking diet |
- |
- |
- |
- |
097 [1] 97 💬 |
854 |
Other: hyperbaric oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
097 [2] 97, 226 💬 |
855 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 [1] 97 💬 |
856 |
Other: intensify treatment with the existing drug |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
857 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
858 |
Other: measurement of drug (adalimumab/infliximab) |
Adalimumab |
[2] D02597 D02597, D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
859 |
Other: mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
860 |
Other: other biologic agents |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
861 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
862 |
Other: pretreatment antibiotics |
- |
- |
- |
- |
097 [1] 97 💬 |
863 |
Other: saline |
- |
- |
- |
- |
002 [8] 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
864 |
Other: therapy education |
- |
- |
- |
- |
097 [1] 97 💬 |
865 |
Other: threonine |
Threonine |
[1] D00041 D00041 💬 |
- |
- |
096 [2] 96, 97 💬 |
866 |
Other: ulcerative colitis diet |
- |
- |
- |
- |
097 [1] 97 💬 |
867 |
Overencapsulated azathioprine (imuran) 50 mg tablet |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
097 [1] 97 💬 |
868 |
Overencapsulated mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
869 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
870 |
Ozanimod |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 96, 97 💬 |
871 |
Ozanimod hydrochloride |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 96, 97 💬 |
872 |
Palmitoleic acid |
Palmitoleic Acid |
- |
- |
- |
097 [1] 97 💬 |
873 |
Parnaparin |
Parnaparin |
[1] D07510 D07510 💬 |
SERPINC1 [1] SERPINC1 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
097 [1] 97 💬 |
874 |
Parnaparin sodium |
Parnaparin |
[1] D07510 D07510 💬 |
SERPINC1 [1] SERPINC1 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
097 [1] 97 💬 |
875 |
Pbf-677 |
- |
- |
- |
- |
097 [1] 97 💬 |
876 |
Pct (purecell technologies complex) |
- |
- |
- |
- |
097 [1] 97 💬 |
877 |
Peg |
- |
- |
- |
- |
006 [9] 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
878 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
879 |
Pending |
- |
- |
- |
- |
013 [6] 13, 19, 96, 97, 113, 302 💬 |
880 |
Pentasa |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
881 |
Pentasa 2g sachet prolonged release granules (95%) |
- |
- |
- |
- |
097 [1] 97 💬 |
882 |
Pentasa 500 mg retardtabletten |
- |
- |
- |
- |
097 [1] 97 💬 |
883 |
Pentasa compact 2g, granulate with prolonged release |
- |
- |
- |
- |
097 [1] 97 💬 |
884 |
Pentasa compact 4g, granulate with prolonged release |
- |
- |
- |
- |
097 [1] 97 💬 |
885 |
Pentasa enema |
- |
- |
- |
- |
097 [1] 97 💬 |
886 |
Pentasa prolonged release granules 2g |
- |
- |
- |
- |
097 [1] 97 💬 |
887 |
Pentasa sachet |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
888 |
Pentasa sachet 1 g |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
889 |
Pentasa sachet 1g |
- |
- |
- |
- |
097 [1] 97 💬 |
890 |
Pentasa sachet 2 g |
- |
- |
- |
- |
097 [1] 97 💬 |
891 |
Pf 06687234 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
892 |
Pf-00547659 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
893 |
Pf-00547659 sc injection |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
894 |
Pf-05230917 |
- |
- |
- |
- |
097 [1] 97 💬 |
895 |
Pf-05285401 |
- |
- |
- |
- |
097 [1] 97 💬 |
896 |
Pf-06480605 |
- |
- |
- |
- |
097 [1] 97 💬 |
897 |
Pf-06480605 100 mg/ml |
- |
- |
- |
- |
097 [1] 97 💬 |
898 |
Pf-06651600 |
PF-06651600 |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
899 |
Pf-06651600 10 mg |
PF-06651600 |
- |
- |
- |
097 [1] 97 💬 |
900 |
Pf-06651600 50 mg |
PF-06651600 |
- |
- |
- |
096 [2] 96, 97 💬 |
901 |
Pf-06651600-15 |
PF-06651600 |
- |
- |
- |
096 [2] 96, 97 💬 |
902 |
Pf-06687234 |
- |
- |
- |
- |
097 [1] 97 💬 |
903 |
Pf-06700841 |
PF-06700841 |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
904 |
Pf-06700841 25 mg |
PF-06700841 |
- |
- |
- |
096 [2] 96, 97 💬 |
905 |
Pf-06700841 5 mg |
PF-06700841 |
- |
- |
- |
096 [2] 96, 97 💬 |
906 |
Pf-06700841-15 |
PF-06700841 |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
907 |
Pf-06826647 |
- |
- |
- |
- |
097 [1] 97 💬 |
908 |
Pf-06826647 100 mg qd |
- |
- |
- |
- |
097 [1] 97 💬 |
909 |
Pf-06826647 300 mg qd |
- |
- |
- |
- |
097 [1] 97 💬 |
910 |
Pf-06826647 600 mg qd |
- |
- |
- |
- |
097 [1] 97 💬 |
911 |
Pf-6826647 400 mg qd |
- |
- |
- |
- |
097 [1] 97 💬 |
912 |
Pfefferminzblätter 1ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
913 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
914 |
Phosphatidylcholine |
Lecithin |
[1] D04682 D04682 💬 |
- |
- |
097 [1] 97 💬 |
915 |
Photodynamic therapy with gliolan |
- |
- |
- |
- |
097 [1] 97 💬 |
916 |
Picosulfate |
Picosulfuric acid |
- |
- |
- |
097 [2] 97, 291 💬 |
917 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
918 |
Pn-10884a |
- |
- |
- |
- |
097 [1] 97 💬 |
919 |
Pn-943 |
- |
- |
- |
- |
097 [1] 97 💬 |
920 |
Polaprezinc |
Polaprezinc |
[1] D01611 D01611 💬 |
- |
- |
096 [2] 96, 97 💬 |
921 |
Polyethylene glycol |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
096 [5] 96, 97, 235, 276, 299 💬 |
922 |
Polyphenon e® |
- |
- |
- |
- |
097 [1] 97 💬 |
923 |
Pomegranate |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
924 |
Prd5973697 |
- |
- |
- |
- |
097 [1] 97 💬 |
925 |
Prednisolon |
- |
- |
- |
- |
046 [6] 46, 50, 51, 66, 96, 97 💬 |
926 |
Prednisolon jenapharm |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
927 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
928 |
Prednisolone sodium metasulphobenzoate |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
929 |
Prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
930 |
Prednisolone tablets b.p. 5mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
931 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
932 |
Prefilled syringe delivery of golimumab |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
933 |
Previously referred to as medi2070 and amg 139 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
934 |
Prim-dj2727 |
- |
- |
- |
- |
006 [2] 6 , 97 💬 |
935 |
Pro145223 |
- |
- |
- |
- |
097 [1] 97 💬 |
936 |
Pro145223 (ro5490261) |
- |
- |
- |
- |
097 [1] 97 💬 |
937 |
Probiotic |
- |
- |
- |
- |
002 [7] 2 , 6 , 93, 96, 97, 193, 266 💬 |
938 |
Probiotic formula capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
939 |
Probiotic mixture |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
940 |
Probiotics |
- |
- |
- |
- |
094 [4] 94, 96, 97, 291 💬 |
941 |
Procedure: biopsies |
- |
- |
- |
- |
097 [1] 97 💬 |
942 |
Procedure: blood sampling, endoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
943 |
Procedure: colectomy |
- |
- |
- |
- |
097 [1] 97 💬 |
944 |
Procedure: colonoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
945 |
Procedure: colorectal biopsies |
- |
- |
- |
- |
097 [1] 97 💬 |
946 |
Procedure: enema |
- |
- |
- |
- |
097 [1] 97 💬 |
947 |
Procedure: fecal microbiota transplantation |
- |
- |
- |
- |
097 [1] 97 💬 |
948 |
Procedure: fmt |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
949 |
Procedure: gastroscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
950 |
Procedure: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
097 [1] 97 💬 |
951 |
Procedure: infusion of saline |
- |
- |
- |
- |
097 [1] 97 💬 |
952 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 [5] 6 , 13, 19, 96, 97 💬 |
953 |
Procedure: narrow band imaging |
- |
- |
- |
- |
097 [1] 97 💬 |
954 |
Procedure: rectal dialysis |
- |
- |
- |
- |
097 [1] 97 💬 |
955 |
Procedure: rectosigmoidoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
956 |
Procedure: sham hyperbaric air |
- |
- |
- |
- |
097 [1] 97 💬 |
957 |
Procedure: sigmoidoscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
958 |
Procedure: standardized fmt |
- |
- |
- |
- |
097 [1] 97 💬 |
959 |
Procedure: stool samples |
- |
- |
- |
- |
097 [1] 97 💬 |
960 |
Products containing aminosalicylate |
- |
- |
- |
- |
097 [1] 97 💬 |
961 |
Products containing azathioprine or 6-mercaptopurine |
Azathioprine |
[4] D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 [1] HPRT1 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 [1] 97 💬 |
962 |
Proline |
Proline |
[1] D00035 D00035 💬 |
- |
- |
094 [2] 94, 97 💬 |
963 |
Promiten |
- |
- |
- |
- |
097 [1] 97 💬 |
964 |
Propionyl l-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
965 |
Propionyl l-carnitine hydrochloride |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
966 |
Propionyl-l-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
967 |
Propionylcarnitinhydrochlorid |
- |
- |
- |
- |
097 [1] 97 💬 |
968 |
Prv-300 |
- |
- |
- |
- |
097 [1] 97 💬 |
969 |
Ps |
- |
- |
- |
- |
046 [3] 46, 90, 97 💬 |
970 |
Ps-qd |
- |
- |
- |
- |
097 [1] 97 💬 |
971 |
Ps-sp |
- |
- |
- |
- |
097 [1] 97 💬 |
972 |
Psyllium |
Plantago seed |
[1] D05525 D05525 💬 |
- |
- |
097 [1] 97 💬 |
973 |
Psyllium husk |
Plantago seed |
[1] D05525 D05525 💬 |
- |
- |
097 [1] 97 💬 |
974 |
Psyllium husk powder |
Plantago seed |
[1] D05525 D05525 💬 |
- |
- |
097 [1] 97 💬 |
975 |
Ptg-100 |
- |
- |
- |
- |
097 [1] 97 💬 |
976 |
Pur 0110 |
- |
- |
- |
- |
097 [1] 97 💬 |
977 |
Pur 0110 rectal enema |
- |
- |
- |
- |
097 [1] 97 💬 |
978 |
Pur 0110 rectal enema 1000 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
979 |
Pur 0110 rectal enema 250 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
980 |
Pur 0110 rectal enema 500 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
981 |
Puri-nethol |
- |
- |
- |
- |
086 [3] 86, 96, 97 💬 |
982 |
Pv |
- |
- |
- |
- |
013 [3] 13, 97, 215 💬 |
983 |
Qbeco ssi |
- |
- |
- |
- |
097 [1] 97 💬 |
984 |
Raspberry |
Raspberry |
- |
- |
- |
097 [1] 97 💬 |
985 |
Ravagalimab |
- |
- |
- |
- |
053 [2] 53, 97 💬 |
986 |
Rdp58 |
- |
- |
- |
- |
097 [1] 97 💬 |
987 |
Rebamipide |
Rebamipide |
[1] D01121 D01121 💬 |
- |
- |
046 [4] 46, 53, 97, 271 💬 |
988 |
Recombinant factor xiii (rfxiii) |
Factor XIII (human) |
- |
- |
- |
097 [2] 97, 288 💬 |
989 |
Rectabul2mg rectal form |
- |
- |
- |
- |
097 [1] 97 💬 |
990 |
Rectal dialysis |
- |
- |
- |
- |
097 [1] 97 💬 |
991 |
Rectal tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
992 |
Regular treatment |
- |
- |
- |
- |
097 [1] 97 💬 |
993 |
Remestemcel-l |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
096 [2] 96, 97 💬 |
994 |
Remicade |
- |
- |
- |
- |
040 [9] 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
995 |
Remicade (infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
996 |
Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten |
- |
- |
- |
- |
097 [1] 97 💬 |
997 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
998 |
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
999 |
Remsima |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
1000 |
Remsima (ct-p13) |
- |
- |
- |
- |
097 [1] 97 💬 |
1001 |
Remsima (infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 96, 97 💬 |
1002 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
1003 |
Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
1004 |
Remsima and inflectra |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1005 |
Retarded release phosphatidylcholine |
Lecithin |
[1] D04682 D04682 💬 |
- |
- |
097 [1] 97 💬 |
1006 |
Retarded release phosphatidylcholine (rpc) |
Lecithin |
[1] D04682 D04682 💬 |
- |
- |
097 [1] 97 💬 |
1007 |
Rhil-11 |
- |
- |
- |
- |
097 [1] 97 💬 |
1008 |
Rhumab beta7 |
- |
- |
- |
- |
097 [1] 97 💬 |
1009 |
Rhumab beta7, anti beta 7, pro145223 |
- |
- |
- |
- |
097 [1] 97 💬 |
1010 |
Rhumab beta7, anti beta7, pro145223 |
- |
- |
- |
- |
097 [1] 97 💬 |
1011 |
Riboflavin |
Riboflavin |
[3] D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 [8] 13, 38, 46, 96, 97, 162, 168, 265 💬 |
1012 |
Rifaximin |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
006 [6] 6 , 65, 96, 97, 99, 296 💬 |
1013 |
Risankizumab |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 [4] 37, 96, 97, 271 💬 |
1014 |
Risankizumab (genetical recombination) |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
097 [1] 97 💬 |
1015 |
Risankizumab iv |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
1016 |
Risankizumab sc |
Risankizumab |
[1] D11052 D11052 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [2] 96, 97 💬 |
1017 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
1018 |
Rivenprost |
Rivenprost |
- |
- |
- |
097 [1] 97 💬 |
1019 |
Rivenprost (drug) |
Rivenprost |
- |
- |
- |
097 [1] 97 💬 |
1020 |
Ro 549-0261/f04 |
- |
- |
- |
- |
097 [1] 97 💬 |
1021 |
Ro5490261 / f02 |
- |
- |
- |
- |
097 [1] 97 💬 |
1022 |
Ro5490261/f02 |
- |
- |
- |
- |
097 [1] 97 💬 |
1023 |
Ro5490261/f04-02 |
- |
- |
- |
- |
097 [1] 97 💬 |
1024 |
Ro7049665 |
- |
- |
- |
- |
097 [1] 97 💬 |
1025 |
Ro7246311 |
- |
- |
- |
- |
097 [1] 97 💬 |
1026 |
Rosiglitazone |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [5] 46, 75, 97, 222, 265 💬 |
1027 |
Rosuvastatin |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
1028 |
Rosuvastatin calcium |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 [4] 49, 79, 97, 299 💬 |
1029 |
Rosuvastatine eg |
- |
- |
- |
- |
097 [1] 97 💬 |
1030 |
Rpc1063 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1031 |
Rtnv148b igg |
- |
- |
- |
- |
046 [3] 46, 97, 271 💬 |
1032 |
Salicylic acid |
Salicylic acid |
[1] D00097 D00097 💬 |
- |
- |
097 [1] 97 💬 |
1033 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
1034 |
Salmon |
Salmon, unspecified |
- |
- |
- |
096 [3] 96, 97, 225 💬 |
1035 |
Salofalk |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1036 |
Salofalk 1000mg granu-stix |
- |
- |
- |
- |
097 [1] 97 💬 |
1037 |
Salofalk 1000mg granu-stix® |
- |
- |
- |
- |
097 [1] 97 💬 |
1038 |
Salofalk 3g gastro-resistant prolonged-release granules |
- |
- |
- |
- |
097 [1] 97 💬 |
1039 |
Salofalk 4g/60ml klysma |
- |
- |
- |
- |
097 [1] 97 💬 |
1040 |
Salofalk granu-stix 500 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
1041 |
Salofalk® 1000mg granu-stix® |
- |
- |
- |
- |
097 [1] 97 💬 |
1042 |
Salofalk® 500 mg gastro-resistant tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
1043 |
Salofalk® 500 mg tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
1044 |
Salofalk® 500mg |
- |
- |
- |
- |
097 [1] 97 💬 |
1045 |
Salofalk® 500mg granu-stix® |
- |
- |
- |
- |
097 [1] 97 💬 |
1046 |
Sandimmum |
- |
- |
- |
- |
097 [1] 97 💬 |
1047 |
Sandimmun |
- |
- |
- |
- |
097 [2] 97, 226 💬 |
1048 |
Sandimmun 50 mg/ml, infuusiokonsentraatti |
- |
- |
- |
- |
097 [1] 97 💬 |
1049 |
Sandimmun neoral |
- |
- |
- |
- |
060 [3] 60, 97, 226 💬 |
1050 |
Sandinum |
- |
- |
- |
- |
097 [1] 97 💬 |
1051 |
Sar339658 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
1052 |
Sb-656933 |
- |
- |
- |
- |
097 [1] 97 💬 |
1053 |
Sb-656933 tablets |
- |
- |
- |
- |
097 [2] 97, 299 💬 |
1054 |
Sb012 |
- |
- |
- |
- |
097 [1] 97 💬 |
1055 |
Sb5 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
1056 |
Sc12267 |
SC12267 |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
1057 |
Sc12267 (4sc-101) |
SC12267 |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
1058 |
Sch 900050 |
- |
- |
- |
- |
097 [1] 97 💬 |
1059 |
Semi-vegetarian diet |
- |
- |
- |
- |
097 [1] 97 💬 |
1060 |
Ser-287 |
- |
- |
- |
- |
097 [1] 97 💬 |
1061 |
Serum bovine immunoglobulin |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1062 |
Sf257 c59 |
- |
- |
- |
- |
097 [1] 97 💬 |
1063 |
Shingrix |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
1064 |
Shp647 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1065 |
Shr0302 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
1066 |
Simponi |
- |
- |
- |
- |
046 [3] 46, 97, 271 💬 |
1067 |
Simponi (golimumab) |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
1068 |
Simponi® |
- |
- |
- |
- |
046 [3] 46, 97, 271 💬 |
1069 |
Simponi® (golimumab) |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
1070 |
Simulect |
- |
- |
- |
- |
066 [2] 66, 97 💬 |
1071 |
Single dose-group a |
- |
- |
- |
- |
097 [1] 97 💬 |
1072 |
Smartject device delivery of golimumab |
Golimumab |
[1] D04358 D04358 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 [1] 97 💬 |
1073 |
Smoking cigarettes |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1074 |
Smoking of cannabis |
Medical Cannabis |
- |
- |
- |
096 [2] 96, 97 💬 |
1075 |
Sodium hyaluronate |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
053 [2] 53, 97 💬 |
1076 |
Sodium picosulfate/magnesium citrate laxative |
Magnesium |
[1] D03265 D03265 💬 |
- |
- |
097 [1] 97 💬 |
1077 |
Solu-medrol |
- |
- |
- |
- |
013 [7] 13, 49, 50, 51, 53, 97, 211 💬 |
1078 |
Sotrastaurin |
Sotrastaurin |
[1] D09671 D09671 💬 |
PRKCD [4] PRKCD, PRKCE, PRKCH, PRKCQ 💬 |
AGE-RAGE signaling pathway in diabetic complications [28] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
1079 |
Sotrastaurin (inn) acetate |
Acetate |
[1] D09671 D09671 💬 |
PRKCD [4] PRKCD, PRKCE, PRKCH, PRKCQ 💬 |
AGE-RAGE signaling pathway in diabetic complications [28] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
1080 |
Soybean |
Soybean |
- |
- |
- |
097 [1] 97 💬 |
1081 |
Soybean phosphatidylcholine |
Lecithin |
[1] D04682 D04682 💬 |
- |
- |
097 [1] 97 💬 |
1082 |
Spd476 |
- |
- |
- |
- |
097 [1] 97 💬 |
1083 |
Spd476 (mesalazine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
1084 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
1085 |
Spesolimab |
Spesolimab |
- |
- |
- |
037 [3] 37, 96, 97 💬 |
1086 |
Spesolimab iv infusion |
Spesolimab |
- |
- |
- |
097 [1] 97 💬 |
1087 |
Spesolimab sc solution for injection |
Spesolimab |
- |
- |
- |
097 [1] 97 💬 |
1088 |
Sr140333b |
- |
- |
- |
- |
097 [1] 97 💬 |
1089 |
Srt2104 |
- |
- |
- |
- |
097 [1] 97 💬 |
1090 |
St 261 |
- |
- |
- |
- |
097 [1] 97 💬 |
1091 |
St-0529 |
- |
- |
- |
- |
097 [1] 97 💬 |
1092 |
St10-021 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1093 |
St261 |
- |
- |
- |
- |
097 [1] 97 💬 |
1094 |
Standard 2 hours-infusion |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1095 |
Standard therapy |
- |
- |
- |
- |
049 [2] 49, 97 💬 |
1096 |
Standardized anthocyanin-rich extract |
- |
- |
- |
- |
097 [1] 97 💬 |
1097 |
Standardized fodmap |
- |
- |
- |
- |
097 [1] 97 💬 |
1098 |
Stasis |
- |
- |
- |
- |
097 [1] 97 💬 |
1099 |
Stelara |
- |
- |
- |
- |
049 [6] 49, 56, 96, 97, 269, 271 💬 |
1100 |
Stelara® |
- |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
1101 |
Sterile saline for injection |
- |
- |
- |
- |
097 [1] 97 💬 |
1102 |
Steroids |
- |
- |
- |
- |
046 [7] 46, 50, 51, 63, 66, 96, 97 💬 |
1103 |
Stnm01 |
- |
- |
- |
- |
097 [1] 97 💬 |
1104 |
Stnm01 1.84 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
1105 |
Stw5-ii |
- |
- |
- |
- |
097 [1] 97 💬 |
1106 |
Stw5-ii (iberogast n, bay98-7410) |
- |
- |
- |
- |
097 [1] 97 💬 |
1107 |
Sucrose |
Sucrose |
[1] D00025 D00025 💬 |
- |
- |
062 [3] 62, 96, 97 💬 |
1108 |
Sugar extract |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1109 |
Sulphsalazine, pentasa, asacol, colazide, depentum |
- |
- |
- |
- |
097 [1] 97 💬 |
1110 |
Suspension containing 7500 embryonated viable trichuris suis ova/15ml |
- |
- |
- |
- |
097 [1] 97 💬 |
1111 |
Suspension de microbiote fécal |
- |
- |
- |
- |
097 [1] 97 💬 |
1112 |
Synergy-1 |
- |
- |
- |
- |
097 [1] 97 💬 |
1113 |
Synergy1 |
- |
- |
- |
- |
097 [1] 97 💬 |
1114 |
Sübetaholzwurzel 1ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
1115 |
Süßholzwurzel 1ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
1116 |
Ta-650 |
- |
- |
- |
- |
037 [4] 37, 56, 96, 97 💬 |
1117 |
Ta-650 (infliximab) |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [3] 46, 97, 271 💬 |
1118 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1119 |
Tauroursoursodeoxycholic acid, brand name tudcabil |
- |
- |
- |
- |
097 [1] 97 💬 |
1120 |
Td-1473 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1121 |
Td-1473 dose a |
- |
- |
- |
- |
097 [1] 97 💬 |
1122 |
Td-1473 dose b |
- |
- |
- |
- |
097 [1] 97 💬 |
1123 |
Td-1473 dose c |
- |
- |
- |
- |
097 [1] 97 💬 |
1124 |
Td-3504 |
- |
- |
- |
- |
097 [1] 97 💬 |
1125 |
Telotristat |
Telotristat |
[1] D09973 D09973 💬 |
TPH1 [2] TPH1, TPH2 💬 |
Folate biosynthesis [4] Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism |
097 [1] 97 💬 |
1126 |
Telotristat etiprate |
Telotristat |
[1] D09973 D09973 💬 |
TPH1 [2] TPH1, TPH2 💬 |
Folate biosynthesis [4] Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism |
097 [1] 97 💬 |
1127 |
Terbinafine |
Terbinafine |
[2] D02219 D02219, D02375 D02375 💬 |
- |
- |
097 [1] 97 💬 |
1128 |
Tetomilast |
Tetomilast |
- |
- |
- |
096 [2] 96, 97 💬 |
1129 |
Tetracycline |
Tetracycline |
[1] D00201 D00201 💬 |
- |
- |
013 [4] 13, 46, 53, 97 💬 |
1130 |
Thalidomide |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 [20] 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
1131 |
Thalidomide pharmion |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [3] 85, 96, 97 💬 |
1132 |
Threonine |
Threonine |
[1] D00041 D00041 💬 |
- |
- |
086 [3] 86, 96, 97 💬 |
1133 |
Thrx-139060 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1134 |
Tj301 300mg |
- |
- |
- |
- |
097 [1] 97 💬 |
1135 |
Tj301 600mg |
- |
- |
- |
- |
097 [1] 97 💬 |
1136 |
To be confirmed |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
1137 |
To be requested |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1138 |
Tofacitinib |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 [12] 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
1139 |
Tofacitinib citrate |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [5] 46, 49, 97, 107, 271 💬 |
1140 |
Tofacitinib citrate (clinical trial image) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1141 |
Tofacitinib citrate (phase iii formulation) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1142 |
Tofacitinib citrate (proposed commercial formulation - debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1143 |
Tofacitinib citrate (proposed commercial formulation – debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 97 💬 |
1144 |
Tofacitinib citrate (proposed commercialformulation - debossed) |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1145 |
Top1288 |
- |
- |
- |
- |
097 [1] 97 💬 |
1146 |
Top1288 rectal solution |
- |
- |
- |
- |
097 [1] 97 💬 |
1147 |
Tp05 |
- |
- |
- |
- |
097 [1] 97 💬 |
1148 |
Tp05 coating a |
- |
- |
- |
- |
097 [1] 97 💬 |
1149 |
Tp05 coating b |
- |
- |
- |
- |
097 [1] 97 💬 |
1150 |
Tp05 coating d |
- |
- |
- |
- |
097 [1] 97 💬 |
1151 |
Tp05 coating e |
- |
- |
- |
- |
097 [1] 97 💬 |
1152 |
Tp05 coating h |
- |
- |
- |
- |
097 [1] 97 💬 |
1153 |
Traditional treatments |
- |
- |
- |
- |
097 [1] 97 💬 |
1154 |
Tralokinumab |
Tralokinumab |
[1] D09979 D09979 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [2] 85, 97 💬 |
1155 |
Treatment algorithm a |
- |
- |
- |
- |
097 [1] 97 💬 |
1156 |
Treatment algorithm b |
- |
- |
- |
- |
097 [1] 97 💬 |
1157 |
Treatment algorithm c |
- |
- |
- |
- |
097 [1] 97 💬 |
1158 |
Tremfya |
- |
- |
- |
- |
037 [2] 37, 97 💬 |
1159 |
Tremfya® |
- |
- |
- |
- |
037 [2] 37, 97 💬 |
1160 |
Trexan |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
1161 |
Trexan inj 25 mg/ml |
- |
- |
- |
- |
097 [1] 97 💬 |
1162 |
Trichuris suis eggs |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1163 |
Trichuris suis ova |
- |
- |
- |
- |
013 [4] 13, 46, 96, 97 💬 |
1164 |
Trichuris suis ova (tso) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1165 |
Tris |
Tromethamine |
[1] D00396 D00396 💬 |
- |
- |
096 [2] 96, 97 💬 |
1166 |
Tso |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
1167 |
Ucb4940 |
- |
- |
- |
- |
046 [3] 46, 97, 271 💬 |
1168 |
Ucmsc group |
- |
- |
- |
- |
097 [1] 97 💬 |
1169 |
Udca |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
067 [5] 67, 93, 94, 97, 296 💬 |
1170 |
Umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
013 [5] 13, 46, 57, 97, 113 💬 |
1171 |
Unknown |
- |
- |
- |
- |
067 [2] 67, 97 💬 |
1172 |
Upadacitinib |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
040 [7] 40, 41, 46, 49, 96, 97, 271 💬 |
1173 |
Upadacitinib (abt-494) |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1174 |
Upadacitinib - direct compression-yellow |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1175 |
Upadacitinib - wet granulation-yellow |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1176 |
Upadacitinib -direct compression-yellow |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 [1] 97 💬 |
1177 |
Updacitinib (abt-494) |
- |
- |
- |
- |
097 [1] 97 💬 |
1178 |
Ur-12746-s |
- |
- |
- |
- |
097 [1] 97 💬 |
1179 |
Urbason |
- |
- |
- |
- |
013 [3] 13, 97, 222 💬 |
1180 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
006 [8] 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
1181 |
Ursodiol |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
008 [6] 8 , 20, 93, 97, 234, 299 💬 |
1182 |
Ursodiol (ursodeoxycholic acid, udca) |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
097 [1] 97 💬 |
1183 |
Ursofalk |
- |
- |
- |
- |
093 [4] 93, 94, 96, 97 💬 |
1184 |
Ustekinumab |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
1185 |
Ustekinumab dose based on bsa and body weight |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
097 [1] 97 💬 |
1186 |
Ustekinumab iv |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [2] 49, 97 💬 |
1187 |
Ustekinumab iv infusion |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [2] 96, 97 💬 |
1188 |
Ustekinumab sc |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [2] 49, 97 💬 |
1189 |
Ustekinumab sc injection |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 [2] 96, 97 💬 |
1190 |
Usual current care |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1191 |
Uttr1147a |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1192 |
Uttr1147a, il22-fc, il-22fc |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1193 |
Uttr1147a/ro7021610 (active) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1194 |
V565 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1195 |
Vaccine vivotif + vaccine dukoral |
- |
- |
- |
- |
097 [1] 97 💬 |
1196 |
Vaccine vivotif + vaccine dukoral + oats |
Oat |
- |
- |
- |
097 [1] 97 💬 |
1197 |
Valganciclovir |
Valganciclovir |
[1] D02495 D02495 💬 |
- |
- |
028 [6] 28, 60, 85, 97, 299, 331 💬 |
1198 |
Vaminolac |
- |
- |
- |
- |
097 [1] 97 💬 |
1199 |
Vaminolac, komb. |
- |
- |
- |
- |
097 [1] 97 💬 |
1200 |
Vamorolone |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [2] 97, 113 💬 |
1201 |
Vamorolone 4% suspension for oral dosing |
Vamorolone |
[1] D11000 D11000 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
1202 |
Vancomycin |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
046 [7] 46, 70, 94, 96, 97, 296, 299 💬 |
1203 |
Vancomycin pre-treat |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
097 [1] 97 💬 |
1204 |
Vancomycin pre-treatment |
Vancomycin |
[2] D00212 D00212, D00926 D00926 💬 |
- |
- |
097 [1] 97 💬 |
1205 |
Vatelizumab |
Vatelizumab |
- |
- |
- |
013 [2] 13, 97 💬 |
1206 |
Vb-201 |
VB-201 |
- |
- |
- |
097 [1] 97 💬 |
1207 |
Vb-201 160mg |
VB-201 |
- |
- |
- |
097 [1] 97 💬 |
1208 |
Vedolizumab |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 [3] 94, 96, 97 💬 |
1209 |
Vedolizumab 108 mg sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
1210 |
Vedolizumab 300 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
1211 |
Vedolizumab 300 mg iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
1212 |
Vedolizumab injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
1213 |
Vedolizumab intravenous (iv), vedolizumab subcutaneous (sc), placebo iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
1214 |
Vedolizumab intravenous injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1215 |
Vedolizumab iv |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 [3] 94, 96, 97 💬 |
1216 |
Vedolizumab iv, placebo iv, placebo sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
1217 |
Vedolizumab iv, placebo sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 [1] 97 💬 |
1218 |
Vedolizumab sc |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1219 |
Vedolizumab sc 108 mg |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1220 |
Vedolizumab subcutaneous injection |
Vedolizumab |
[1] D08083 D08083 💬 |
ITGA4 [2] ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy [15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 [2] 96, 97 💬 |
1221 |
Vidofludimus |
Vidofludimus |
- |
- |
- |
013 [5] 13, 46, 94, 96, 97 💬 |
1222 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 [4] 13, 94, 96, 97 💬 |
1223 |
Vidofludimus calcium dihydrate |
Calcium |
- |
- |
- |
097 [1] 97 💬 |
1224 |
Vigantol |
- |
- |
- |
- |
013 [4] 13, 65, 96, 97 💬 |
1225 |
Vigantol oel |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1226 |
Vigantol oel tm |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1227 |
Visilizumab |
Visilizumab |
[1] D06314 D06314 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 [2] 96, 97 💬 |
1228 |
Visilizumab (hum291 |
Visilizumab |
[1] D06314 D06314 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
097 [1] 97 💬 |
1229 |
Visilizumab (nuvion) |
Visilizumab |
[1] D06314 D06314 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
097 [1] 97 💬 |
1230 |
Visilizumab (nuvion® |
Visilizumab |
[1] D06314 D06314 💬 |
CD3D [3] CD3D, CD3E, CD3G 💬 |
Chagas disease [11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
097 [1] 97 💬 |
1231 |
Vitamin b2 |
Riboflavin |
[3] D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
097 [1] 97 💬 |
1232 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 [21] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
1233 |
Vitamin d drops |
Vitamin D |
- |
- |
- |
096 [2] 96, 97 💬 |
1234 |
Vitamin d3 |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 [11] 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
1235 |
Vitamin e |
Vitamin E |
[1] D02331 D02331 💬 |
- |
- |
002 [11] 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
1236 |
Vitamin e 800iu |
Vitamin E |
[1] D02331 D02331 💬 |
- |
- |
096 [2] 96, 97 💬 |
1237 |
Vitamin k |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [5] 13, 46, 96, 97, 299 💬 |
1238 |
Vitamin k 10 mg |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
096 [2] 96, 97 💬 |
1239 |
Vivotif |
- |
- |
- |
- |
097 [1] 97 💬 |
1240 |
Vsl#3 |
- |
- |
- |
- |
096 [3] 96, 97, 291 💬 |
1241 |
Vsl#3 (original de simone formulation) |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1242 |
Vsl#3® |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1243 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1244 |
Warfarin 10 mg |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
096 [2] 96, 97 💬 |
1245 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1246 |
Wharton jelly mesenchymal stem cells |
- |
- |
- |
- |
097 [1] 97 💬 |
1247 |
Xeljanz |
- |
- |
- |
- |
046 [3] 46, 97, 271 💬 |
1248 |
Xeljanz 5 mg film-coated tablets |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
1249 |
Xeljanz 5mg film-coated tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
1250 |
Z-206 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1251 |
Zessly |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
1252 |
Zoenasa-1:4 |
- |
- |
- |
- |
097 [1] 97 💬 |